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ABSTRACT
The use of point-of-care (POC) diagnostic systems holds great promise for the early detection of
various diseases. However, detection limits for commercially available POC systems have not
been able to meet the lower cutoffs offered by the specialized laboratory testing methods. Research
into the use of carbon nanofibers (CNFs) grown on glass microballoons in POC devices was
studied.

The growth of several millions of the CNFs on each microballoon (NMBs) presented a large
surface area with high probability of capturing minute concentrations of biospecies.
Functionalization of the NMBs with the carboxyl group needed for biospecies conjugation was
achieved by air oxidation. This oxidation process makes our process environmental friendly to
other downstream processes. Primary IgG was immobilized on glass slides.

An

immunochromatographic device was developed using a sandwich assay protocol to detect varying
concentrations of immobilized anti-IgG on the slides. Covalent conjugated NMBs with secondary
IgG were used in generating both visual and electrical signals. False signals were prevented by
coating both the antibody immobilized slides and NMBs with surfactants. A lower visual detection
limit of 0.010 ng/ml and faster detection (~ 1 min) were achieved for the IgG/anti-IgG detection.

This promising result led to the modification of the immunochromatographic device for the
detection of malaria infection and pregnancy. Plasmodium falciparum histidine rich protein-2
(PfHRP-2) and Plasmodium vivax merozoites surface protein-1 (PvMSP-1) antigen were used for
malaria testing. Human chorionic gonadotropin (hCG) was also used for pregnancy testing. The
approach made it possible to detect PfHRP-2 and PvMSP-1 in PBS over their linear range of 0.01

xi

– 10 ng/ml. The ultrasensitive approach resulted in detecting as low as 0.025 ng/ml of PfHRP-2
and 0.025 ng/ml of PvMSP-1in PBS using visual signal within only one minute of testing. The
approach is highly selective and specific in identifying PfHRP-2 from a mixed solution of PfHRP2 and PvMSP-1. A visual detection limit of 0.050 ng/ml of hCG in PBS was also obtained for the
pregnancy antigen. Thus, the highly reactive, rapid, selective and signal amplification capabilities
of NMBs is a promising tool for use in POCs for the early diagnosis of malaria and pregnancy.

xii

CHAPTER 1
INTRODUCTION
1.1

Motivation

The advancement in technology is continuously changing the way the world operates.
Improvements in disease detection devices are no exceptions. Research of incorporating carbon
nanosized particles in disease detection devices has been growing. Carbon nanofibers (CNFs) with
their high aspect ratios and large surface areas have been reported to provide numerous binding
sites for biological entities [1-3]. Several millions of these CNFs can be grown on a glass
microballoon (NMBs) thereby providing extensive areas for binding with bio species. The NMBs
conjugated with secondary antibody will therefore have a significantly higher probability of
capturing antigens in solution. Exploiting this advantage can lead to the discovery of a different
generation of rapid detection kits (RDTs). These kits will have the advantages of being sensitive
to minute protein concentrations and the ability to sense biomolecules in real time.

1.1.1 Point-of-Care (POC) Diagnostic Devices
Biosensors are devices that use specific biochemical reactions mediated by isolated enzymes,
immunosystems, tissues, organelles or whole cells to detect chemical compounds usually by
electrical, thermal or optical signals [4]. These sensors detect, transmit and record information
regarding physiological, chemical and biological compounds of a living environment with the help
of a specific biological recognition element. The ability of a biosensor to function effectively
depends on its sample handling, bio-recognition, transduction and signal interpretation
efficiencies. Biosensors are designed to analyze minute volumes of analyte in solution, usually a
drop of blood. Bio-recognition is achieved when the biomolecule recognizes the target analyte.
The transducer converts the recognition event into measurable signals generated in the form of
1

electrical, optical, thermal, chemical, mechanical or magnetic outputs [5-10]. Biomolecules
currently being used are antibodies [6], enzymes [5, 7], deoxyribonucleic acid (DNA) [11], and
whole cells [12].

There is an increasing demand for inexpensive and reliable sensors for use in doctor’s offices,
emergency and operating rooms. Ultimately, patients themselves should reliably be able to use
biosensors in the monitoring of a clinical condition, such as diabetes and malaria. Currently, the
major biosensor market is mainly found in highly developed countries. However, most of the top
deadly diseases, such as malaria, diarrhea and tuberculosis, are found in developing countries
where access to disease detection in some areas is greatly limited. These diseases require highly
specialized equipment and personnel in their diagnostics. Producing biosensors for use in detecting
these deadly diseases, and making them widely available and affordable, will help in detection at
early stages leading to less mortality of patients.

POC test kits are gaining increasing popularity in the world [13]. Their need in low-resource
settings are striking. These kits are used in lieu of diagnostic testing in hospital laboratories,
because conventional services may be too distant, prohibitively costly, or in mostly cases
unavailable. Gains have started to be obtained by healthcare professionals in rapidly obtaining
common laboratory results either at or near patient’s bedside or in their offices. Benefits from their
use will include the improvement in decision making and triage, reduction in operating times,
reduction in emergency room visits, reduction in number of outpatient clinic visits, reduction in
number of hospitalization, and ensuring optimal use of health professionals.
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Rapid detection kits (RDT) are based on immunoassays methods that are able to directly identify
the presence of microorganism in a sample. These rely on the specific binding of an antigen to its
antibody. This method combines the specificity of antibodies which are usually immobilized on
solid supports, like polystyrene tubes or microtiter plates, with the sensitivity of conjugated
enzymes [14]. However, an incubation period of a few minutes is necessary prior to the
interpretation of the biochemical reactions. Examples of some of these RDT are the Clearblue
pregnancy kits [15] which has 3 minutes incubation time and BinaxNow Malaria kit [16] with 10
minutes incubation period. Although these immunoassay kits are rapid, real time sensing devices
are the ultimate goal for all biosensing devices, hence the need for incorporation of instant labels.
Also, their mechanism is based on fluorescent emission which requires the use of specific dyes for
labeling of samples [14]. False alarms sometimes result due to the use of these dyes leading to
inconclusive or wrong diagnostics. The use of alternate labeling agents, such as Carbon
Nanofibers, in RDT will lead to improvements in their outputs.

1.1.2 Carbon Nanofibers
The existence of carbon nanostructures dates back to the 19th century [17, 18]. However, it was in
the early 1980s that unprecedented research began in the area of carbon nanostructures [19-23].
This led to a rapid increase in the numbers of discovered carbon nanostructures. The fullerenes,
nanotubes, carbon toroidal structures, nanocones, and the helicoidal tubes [19-23] are examples of
those discovered few years thereafter. The fibrous nanostructures, carbon nanotubes (CNTs) and
CNFs, have ordered arrangements with high aspect ratio, ultra-light weight, biocompatibility, high
reactivity, high mechanical strength, high thermal conductivity, metallic or semi-metallic
behavior, and very high surface area which can be exploited in biosensing devices [24].

3

Rolled graphene sheets, hexagonally arranged sp2 bonded carbon atoms, are the building block of
the carbon nanofibers. In CNFs, these graphene sheets are stacked at an angle to the fiber axis
whiles the CNTs have the sheets running parallel to the fiber axis [25]. CNFs therefore have
relatively larger diameters, up to 500 nm, and up to a few millimeters in length. The overwhelming
research in CNTs after its discovery by Iijima [20] attracted and continues to draw interest in
several scientific fields such as chemistry, physics, biology, medicine, biochemistry and
electronics. However, CNFs have some advantages over CNTs in microfluidic applications due to
their larger inner diameter and the presence of graphene edge planes, which are ledges of carbon
that protrude from the surface at regular intervals [26]. The fibrous carbon nanostructures are also
known to be highly reactive at their end caps and the defect regions on their sidewalls [27]. These
sites, when exploited for chemically immobilizing biological species in biosensing applications,
will lead to the fabrication of highly sensitive devices. Price and his colleagues reported the
bonding of bone cells with CNFs due to the protrusion of these ledges of carbon in the CNFs
structure [26]. These numerous plane terminations of CNFs, unlike the passive graphene surfaces
of CNTs, can be modified easily and applied in biosensing applications [3].

1.1.3 Carbon Nanofibers Grown on Glass Microballoons (NMBs)
Research in the potential use of CNTs and CNFs based nano-devices for ultrasensitive sensing is
widely being pursued with several demonstrations confirming the exciting possibilities ahead [2832]. Smaller and lightweight sensors with higher sensitivity and ability to sense in real time will
revolutionize the way detections are made. However, utilization of carbon nanofibers in sensing
devices pose challenges. Though they lead to improvements in the sensitivity of these devices,
their reliability is questionable. This comes to light when attempting detection of multiple

4

molecules in a sample. A large range of signal fluctuations has been encountered due to statistical
reasons [33]. The ability to organize these fibers into well-defined spatial orientations will improve
their reliability leading to their potential use in various applications.

Chemical modiﬁcation combined with self-assembly of individual CNTs/CNFs [34, 35] and a
multistep chemical vapor deposition (CVD) process [36] are some methods being used to construct
carbon nanofiber superstructures. Employing a direct and relatively simple method of enabling the
position of CNFs on the surface of other useful three dimensional structures could help grow CNFs
forest for applications in biosensing devices. Hollow nickel microspheres [37], ceramic beads [38],
and alumina microparticles [39] are examples of some of the three dimensional structures on which
these fibrous nanostructures have been synthesized. Figure 1.1 shows some of these
superstructures.
(a)
(b)

(c)

Figure 1.1
CNTs grown on (a) hollow nickel microsphere [37], (b) ceramic beads [38] and (c)
alumina microparticle [39].

Catalyst coated hollow glass microballoons made from soda-lime borosilicate glass also has a
potential of being used in growing vertically aligned CNFs using the CVD route. Growing these
CNFs on glass microballoons (NMBs) has the potential of being utilized in point-of-care
diagnostic devices. These immunosensor devices may provide high reliability, ultra-low detection
5

limits, improved sensitivity, easy handling of labeling materials, and ability to quantify the level
of infection. Their use could lead to medical results being made available quicker to the patient
and the care team allowing immediate clinical management decisions to be made.

1.2

Research Objectives

The ability to provide immediate diagnosis to patients has been an area of study in the sensing
community for some time now. Various rapid detection kits have evolved over time. The
pregnancy test kit which analyzes urine samples in a minimum of 3 minutes and the malaria rapid
test kits which have a minimum detection time of 10 minutes are a few of POC kits commercially
available. More sensitive and real time detection can be achieved if NMBs are incorporated into
these devices.

This study proposes the development of a POC testing kit for microorganisms in which NMBs are
used as label. Successful growth of several CNFs on a glass microsphere will increase the
probability of capture of antigens thereby improving the reliability of the CNFs for electrical and
optical detection. This will be the first attempt in fabricating instant diagnostics POC devices with
ultra-low detection limit, high sensitivity and selective detection of minute concentrations of
multiple disease causing antigens simultaneously. Plasmodium falciparum, Plasmodium vivax,
and human chorionic gonadotropin will be used as markers for the study. Visual observation and
electrical measurement will be employed for signal detection. Quantification of varying marker
concentrations will be obtained from electrical measurements.

6

1.3

Outline of Dissertation

This dissertation contains six chapters. Chapter 1 presents the motivation and objectives of this
research. It also introduces POC devices, CNFs, and CNFs grown on 3D structures. Chapter 2
describes the relevant structures and surface functionalization protocols for CNFs. Experimental
procedures and results for fabricating and functionalizing the surface of CNFs are also presented.
Chapter 3 introduces antibodies, their binding to CNFs, and modes of preventing nonspecific
binding in CNFs. Studies on the conjugation of immunoglobulin G (IgG) and anti-IgG to NMBs
and their use as a platform in immobilizing the conjugated NMBs on glass slides are reported.
Chapter 4 introduces malaria and the various methods of diagnosing the disease. Pregnancy, a
clinical condition is also introduced and its diagnostic methods briefly outlined. An
immunochromatographic sensor is proposed that incorporates NMBs to selectively and sensitively
detect ultra-low concentrations of malaria and pregnancy antigens in solution. Results and
discussions from the sensor are presented. Finally, Chapter 5 summarizes the results obtained from
the study and proposes further work.
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CHAPTER 2
FABRICATION AND SURFACE FUNCTIONALIZATION OF CARBON NANOFIBERS
GROWN ON GLASS MICROBALLOONS
2.1

Introduction

The study and applications of carbon nanostructures have grown since the reported discovery of
CNTs by Iijima in 1991 [20]. Although CNTs and CNFs are synthesized using similar setups, their
major difference results from the angle of inclination of the rolled graphene sheets. While CNTs
are rolled up in a cylindrical form with their plane parallel to the fiber axis, CNFs have their
graphene layers inclined with respect to their fibril axis [40]. These differences in inclination are
as a result of differences in fabrication temperatures. Hence CNFs are relatively larger in diameter,
up to 500 nm, compared to the CNTs. Benefits of using CNFs over CNTs include relatively easier
synthesis methods and ease in their dispersion and functionalization. Other properties of these
materials have been reported to be similar by several authors [25, 40-43] although better
controllability of the location and size of CNFs compared with CNTs have also been reported [44].

Arc discharge, laser ablation and chemical vapor deposition (CVD) remain the most widely used
techniques in fabricating CNTs/CNFs due to their ability to synthesis large quantities of the
CNTs/CNFs. The discovery of CNTs by Iijima was made possible by the arc-discharge
evaporation method [20]. Since then, several researchers have employed modified methods of this
process in their approach [45-47]. Even though this method has the advantage of being a simple
process that produces CNTs/CNFs with excellent crystallinity, its products do suffer from low
purity [46, 48]. The laser ablation method requires complex and expensive equipment and give a
limited yield as well [48]. Purification and separation of products from both the arc-discharge and
laser ablation techniques have negative impact on subsequent use of the CNTs/CNFs. The CVD
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process is much more amenable to scale-up allowing the fabrication of relatively large amount of
nanofibers with the least cost. CVDs also enable synthesis to be achieved under relatively mild
conditions, giving more control over the growth process. This has allowed the growth of aligned
and ordered CNT/CNF structures in a controllable manner on various surfaces [37, 39, 49, 50].

Various structures obtained from the CVD synthesis of CNFs have been proposed. However, the
ability to control and tailor the structure of CNFs demonstrated by Rodriquez et al. [51] is the
adopted one by most researchers. It involves the creation of a faceted catalyst particle on which
the carbon feedstock decomposes on certain surfaces with carbon precipitation occurring on the
remaining surfaces of the catalyst [51, 52]. The conditions of growth favors the formation of
graphene sheets which grow parallel to the surface of the faceted catalyst particle which in turn
determines the angle between the planes and the fibril axis [53]. Under different conditions of
gases and catalyst compositions, and temperature, the faceted catalysts undergo surface
reconstruction forming unique geometrical shapes which drive the formation of the different CNFs
structures [51, 54, 55]. The use of acetylene and hydrogen gas mixtures, fabrication temperatures
around 600 C, and nickel and its alloys as catalysts, have been reported to favor the formation of
the herringbone structure [51, 52]. The presence of excess hydrogen have been reported to favor
the termination of the large number of dangling bonds at the edges of the stacked graphene
platelets, whereas the more stable form of the carbon filament with closed tubular graphene sheets
and without dangling bonds are favored without hydrogen termination [25, 56].

The fabricated CNFs appear as powders resembling soot. The individual nanofibers are generally
combined into aggregates which can often be seen even by the naked eye. They have extraordinary
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thermal, optical, mechanical and electrical properties. The exploitation of their extraordinary
electrical and optical properties can be achieved commercially if the nanofibers are applied as
carbon nanofiber superstructures. This will eliminate the signal fluctuations associated with
measurements from individual fiber strands and also improve their visibility due to the cluster of
nanofibers produced. The well-known techniques for consolidating metallic and ceramic particles,
pressing and sintering, cannot be applied to CNFs. As a result, other methods are being used to
produce forests of CNTs/CNFs on three dimensional substrates [37-39, 49, 50, 57].

Successful grafting of CNTs/CNFs forests on the surfaces of spherical substrates have been
achieved by different researches [37-39, 49, 50, 57]. These spheres provide added advantages in
that they can be stacked easily while still providing much larger outer surfaces than conventional
flat wafers while they also have the best fluidity among all shapes of solid particles. Xiang et al.
[50] successfully used a large-scale production technique to fabricate aligned CNT arrays on
ceramic spheres comprising of SiO2, Al2O3, and ZrO2. They reported being able to use their
product in constructing a conducting matrix in a polymer as well as in electromagnetic shielding
applications. Multi-scale hybrid structures of multi-walled CNTs and micrometric alumina
particles have also been produced using chemical vapor deposition process with promising
application in advanced multifunctional composite materials [39]. CNFs on glass microballoons
(NMBs) have been fabricated by the author in the laboratory and NMBs’ use in syntactic foams
[58] and thin film conductive nanocomposites and sensors [59] have been reported by colleagues.
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2.2

Structure of CNF

The building blocks of both CNF and CNT are the graphene layers. The angle of inclination of
these layers with respect to the fibril axis differentiates the CNFs from the CNTs. While the CNTs
have parallel orientation to the fiber axis making them cylindrical, the CNFs are inclined at varying
angles to the fibril axis. The different inclination angles have led to the discovery of different CNF
structures. The various identifiable structures of CNFs are shown in Figure 2.1. The chemical
nature of the catalyst, the conditions of its pretreatment, the composition and flow rate of the gas
mixture, the duration of the synthesis are properties related to the structure of the CNFs [60-63].
The electrical and optical properties are also largely dependent on their structures [40, 64, 65].

(a) Platelet

(b) Platelet (Spiral)

(c) Fishbone hollow
core

(d) Fishbone solid core

(e) Ribbon

(f) Stacked cup

Figure 2.1

Schematics of the different structures of CNFs [40].
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Platelet CNFs have the graphene layers perpendicular to the fiber axis {Figure 2.1(a)} and with
fibril widths up to about 100 nm [40]. Platelets do contain non-negligible amounts of hydrogen or
other heteroatoms for the stabilization of their structure. The catalyst used is usually located in the
mid portion of the fiber resulting in bidirectional fibers [51, 66]. Coiled structures of these platelets
have also been reported [67, 68]. CNF structures produced with the graphene layers inclined at
angles less than 90 to the fiber axis have been identified as fishbone. The inclined angle has been
reported to depend, among other parameters, on the presence of hydrogen in the feedstock [56].
The resulting structures are either hollow core {Figure 2.1(c)} [69] or solid cores {Figure 2.1(d)}
[51]. The structure of ribbon CNFs and multi-walled carbon nanotubes (MWCNTs) bear striking
resemblance. The ribbon CNFs {Figure 2.1(e)} comprise of straight unrolled graphene layers
running parallel to the fiber axis [51]. The cylindrical cross-sections of the MWCNT enables their
distinction to be made. The last identified structure, stacked cup CNFs, is made up of a spiral
graphene layer along the fibril axis. They have been reported to have a circular cross-section with
a huge hollow space [70]. This structure is favored by the use of a molten catalyst [40].

Despite distinct differences in the internal structures of CNFs and CNTs, the term CNTs are more
often used to classify CNFs as well since they can display similar morphology to MWCNTs;
however, their physical and chemical properties are quite different. While CNTs are reported to
display ballistic electron transport [71] and diamond like tensile strength [41] along their axis,
CNFs have proven their robustness as individual, freestanding structures with higher chemical
reactivity and electron transport across their sidewalls. Their high chemical reactivity makes them
candidate materials for applications such as biosensing which requires selective functionalization
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and attachment of biological molecules while their outstanding electron transport ability is
exploited in their use in electrochemical applications.

The graphene sheet is a flat monolayer of carbon atoms packed tightly into a two dimensional and
crystallizes in a honeycomb lattice. Carbon has an outer shell containing the 2s22p2 orbitals and
the hexagonal lattice arrangement of the carbon atoms in graphene allows the formation of two
penetrating sub-lattices, which is a result of its sp2 hybridization [72]. The four valence carbon
electrons only bonds to three other carbon atoms leaving an unoccupied 2p z orbital perpendicular
to the plane of the graphene sheet of the valence atomic bonds. Stable sigma bonds between the
three nearest carbon atoms are formed in the planar orbitals with the remaining free 2pz orbitals
overlapping between neighboring carbon atoms to form weak pie bonds. These out of plane pie
bonds are responsible for the excellent electrical properties of the graphene sheets, and hence the
good conductivities of various CNF structures. The conduction electrons can travel large distances
without being scattered, that’s up to 25000 cm2 per volt-second, which is only 300 times less than
the speed of light [73]. The 2.3% cloudiness on the honeycomb graphene surface leaving over 97%
visual transmission rate gives graphene, and hence CNFs, their extraordinary optical properties
[74].

The structural configuration of CNFs and their high surface area-to-volume ratios therefore allows
the confinement of the free pi electrons around the circumference and length of the CNFs. The
presence of strong covalent and pi bonds and the ability to selectively attach functional groups
makes these structures ideal for use in a wide range of applications such as in biosensors,
composite materials, electronic devices, and field emission displays.
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2.3

Surface Functionalization of CNFs

All known methods of synthesizing of carbon nanostructures have been reported to generate some
amount of amorphous carbon and catalyst nanoparticles as impurities in the final product [45-50].
Hence contamination and their poor solubility in aqueous media have been their major obstacle to
their use in biosensors and other applications. The various techniques, for the purification of the
“as fabricated” carbon nanostructures involve their manipulation into a useful state which consist
of extensive mechanical and chemical processing. These processes change the surfaces of the
carbon nanostructures and more often creates isolated point defects or vacancies, topological
defects, and sp2-sp3 hybridization defects in the hexagon graphene framework. The absence of
carbon atoms from their original positions as a result of incomplete bonding during synthesis
results in the introduction of point defects in the structure. The topographical defects are created
as a result of pentagon and heptagon carbon lattice formation along the carbon nanostructure walls.
Stone-Wales defects, 2 pentagons and 2 heptagons, have a unique characteristic in adsorption of
hydrogen and other foreign atoms and this has a potential in applications such as biosensing and
energy storage. The interaction between the adsorbing hydrogen and carbon atoms during the
synthesis process also leads to the generation of the hybridization defects [75]. Purification
techniques leads to the production of cleaner materials as well as the introduction of functional
groups which makes it easier for further processing of the carbon nanostructures. They however,
results in partial loss of structure and material as well as increased number of defects on their
surfaces.

The presence of van der Waals forces in these carbon nanostructures is also responsible for the
agglomeration of the individual strands in various aqueous media. Due to their smaller sizes, these
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van der Waals forces are stronger in carbon nanostructures, requiring the use of functionalization
techniques to aid and maintain dispersion. With all the carbon nanostructures, the CNFs are less
affected by the van der Waals forces and tend to stay dispersed for longer periods of time.
Controlling the surface chemistry of these CNFs is therefore critical to defining their functionality.
Their surface charge, hydrophobicity, and chemical reactivity can be and have been altered through
both covalent and non-covalent modifications [62, 76-78].

Covalent, or chemical attachment of functional groups takes advantage of the higher reactivity of
carbon atoms at defect sidewalls and the end caps of carbon nanostructures to carry out a series of
reaction steps. Only a smaller fraction undergoes the functionalization compared to the noncovalent type. The direct covalent sidewall functionalization is associated with a change of
hybridization from the sp2 to sp3 losing p-conjugation system on the graphene layer in the process.
Molecules with higher chemical reactivity are used due to the inert nature of the sidewalls [79].

The use of xanthates in the functionalization process has been reported to offer the advantages of
easy processing and versatility towards applications in a multitude of domains [80]. Use of other
molecules such as elemental fluorine in the functionalization of the carbon nanoparticles have
resulted in weaker C-F bonds which provides substitution sites for additional functionalization
[81]. Successful replacement of the fluorine atoms by amino, alkyl and hydroxyl groups have been
achieved [82]. Other methods of sidewall functionalization, including cycloaddition [83], gasphase azide [84], and silylation [85] have also been successfully employed.
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Functionalization of the defect sites and end caps are achieved by oxidative damage to the
nanostructure framework by strong acids and oxidants which results in the formation of carboxyl
acid, ketone, alcohol and ester groups at the sites attacked by the acid. These functional groups
serve to tether many different types of chemical moieties onto the ends and defect sites of these
nanostructures. Treatments of carbon nanostructures with strong acids such as HNO3, H2SO4 or a
mixture of them [86-88], or with strong oxidants such as KMnO4 [89], ozone [90], reactive plasma
[91] tend to open up these structures with the introduction of the functional groups. These
functional groups have rich chemistry and have been used for further chemical reactions in
applications such as biosensing, silanation, and esterification [79, 85, 86].

Covalent functionalization introduces several polar and non-polar functional groups onto the
carbon nanostructures making them soluble in various organic and inorganic solvents. Two major
drawbacks are however associated with these methods. First, ultrasonication and centrifugation
associated with these methods leads to the creation of large number of defects on the sidewalls,
and in some cases, fragmentation of the nanostructures into smaller pieces. These damaging effects
lead to severe degradation in the mechanical properties and the disruption of π electron system.
Electrical and thermal properties of the structure is subsequently reduced since the defect sites tend
to scatter the conducting electrons and phonons [92]. The other major drawback is the effect of the
concentrated acids and strong oxidants on downstream processes. These chemicals are
environmentally unfriendly and may affect the further applications in biosensing and other acid
sensitive use.
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An alternative method of tuning the interfacial properties of the hydrophobic carbon
nanostructures is through the use of non-covalent functionalization. The use of ionic surfactants
such as sodium dodecyl sulfate (SDS), which is widely used in household products such as
shampoo and shaving foam, has been found to be of great value in solubilizing CNTs. The ionic
surfactants operate by transferring a charge to the surfaces of the CNTs. The CNTs are then
dispersed by electrostatic forces with the behavior of the dispersion showing a strong dependence
on pH [93]. Non-ionic surfactants, such as triton X-series, have also been used to solubilize CNTs
in water [94]. These non-ionic surfactants operate using a combination of hydrogen bonding and/or
steric dispersion forces. At high concentrations, these surfactants form micelles, with the CNTs
held in the hydrophobic core of the micelles [93].

The use of relatively small molecules containing planar groups that irreversibly adsorb to the
nanostructure surfaces by π-stacking forces have also been used. Chen et al. [95] used a planar
pyrenyl group to non-covalently functionalize the surface of SWCNT. This formed the van der
Waals bonds and a ‘tail’ consisting of succinimidyl ester group. Finally, helically wrapping the
tubes with linear polymers such as polyvinylpyrrolidone (PVP) and polyethylene glycols (PEG)
have also been successfully used. Zhang et al. [96] used PVP to modify the surface of MWCNTs.
They reported a straightforward and efficient method for dispersing the MWCNTs in water and a
variety of organic solvents with the solvents being kept for up to 2 months without the MWCNT
precipitating out. The use of PEG in non-covalently modifying the surface of carbon
nanostructures have also been reported to improve water solubility and long blood circulation [97].
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2.4

Experimental Procedures

2.4.1 Catalyst Coating of Glass Microballoons
Glass microballoons (MBs), the three dimensional microstructure on which the carbon nanofibers
were synthesized was purchased from 3M Corporation, USA. They are chemically stable
lightweight/high strength hollow glass spheres with a soda-lime-borosilicate composition and a
true density of 0.22 g/cm3. Their diameters range between 5 to 75 µm with their surface amendable
to treatment with a variety of functional coatings [98]. Electroless deposition (ELD) of nickel on
the glass microballoons was achieved using the three stage functionalization, activation and
deposition technique [99]. 3-aminopropyltrimethosxysilane (APTMS), sodium hypophosphite
(NaH2PO2.H2O), nickel (II) chloride hexahydrate (NiCl2.6H2O), and ammonium chloride (NH4Cl)
were purchased from Alfa Aesar Chemicals, MA, USA; palladium (II) chloride (PdCl2) from
Strem Chemicals, Inc., USA; sodium citrate dihydrate (Na3C6H5O7.2H2O) from Mallinckrodt
Chemicals, Inc.; and ammonium hydroxide solution (NH4OH) obtained from BDH Aristar were
used in the ELD process. Temperatures for all processes not stated were carried out at 25 C. The
steps used for Ni deposition are explained in detail below:



Functionalization

Glass microballoons (about 10g) were cleaned repeatedly with acetone, isopropyl alcohol, and
ethanol respectively. The microballoons were filtered from each of the solvents using a vacuum
assisted set-up. The washed microballoons were then dispersed in 700 ml of ethanol.

The washed microballoon/ethanol solution was placed on a combined hot-plate magnetic-stirrer
device and vigorously agitated. 1.4 ml of APTMS was added to the suspension and the stirring
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was allowed to proceed for 2 hours. The functionalized microballoons were washed twice with
ethanol and filtered using the vacuum assisted set-up.



Activation

The functionalized microballoons were transferred to a 700 ml ethanol solution containing 0.14 g
of PdCl2. The mixture stirred and left to react for 2 hours at room temperature. The activated
microballoons were then thoroughly cleaned by washing twice with ethanol and deionized water.
420 ml of deionized water was then added.



Deposition

The electroless solution was prepared by dissolving 4.2 g of NiCl2.6H2O, 1.39 g of NaH2PO2.H2O,
7.0 g of Na3C6H5O7.2H2O, and 6.96 g of NH4Cl in 140 ml of deionized water. The pH of the
solution was adjusted to 8.30 by adding sufficient amount of NH4OH. This solution was introduced
into the 420 ml activated microballoons solution and the temperature raised to 90 C. It was
vigorously stirred and the reaction left to proceed for 15 minutes.

2.4.2 CNF Growth
An OTF-1200X-80-II-F3LV dual zone tube CVD furnace was used for the CNF growth. This
process of growth was first reported by Lee et al. [100] and a schematic of the setup is shown in
Figure 2.2. 20 mg of Ni coated microballoons was uniformly spread on two 40 cm2 silicon wafers.
The wafers were placed in the second heating zone of the furnace. The temperatures of the CVD
zones were set at 850 C and 650 C respectively and the furnace programmed to reach these
temperatures in 40 minutes. An inert atmosphere was maintained in the furnace by flowing 160
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sccm of Ar gas throughout the fabrication process. The growth was carried out in 15 minutes by
flowing a mixture of 100 sccm of H2, 30 sccm of C2H2, and 350 sccm of Ar through a deionized
water maintained at 60 C. After the growth process, the temperatures in the two chambers were
programmed to attain 100 C in 50 minutes. All gas tank pressures were maintained at 5 psi.

Fume Hood

Pressure Gauge

Dual Zone
Furnace

Volume Flow Controller

Water Bubbler

C2H2

Figure 2.2

H2

Ar

Schematic of the CVD system.

2.4.3 Surface Functionalization of CNF
Nitric acid (68% v/v) (HNO3) obtained from Macron Chemicals and H2SO4 (98% v/v) from Fisher
Scientific were used for the acid functional process. As fabricated NMBs was used for the surface
modification studies. The carboxyl groups were grafted onto the surface of the as-fabricated NMBs
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following modifications of two different acidic processes reported by Osorio et al. [101] and Liang
et al. [88]. The first method involved the treatment with nitric acid where 2 mg of NMBs was
refluxed with 2 ml concentrated HNO3 for 24 hours. The second procedure involved the treatment
10 mg of NMBs with 8 ml 1:3 volume concentrated solution of HNO3/H2SO4 also for 24 hours.
The resulting NMBs solutions were filtered and washed using distilled water. Both filtrates were
suspended in 8 M NaoH, obtained from Macron Chemicals, for 24 hours and then filtered. To
neutralize the filtrates, they were rinsed with dilute HCl, obtained from Macron Chemicals,
filtered, washed with an excess of distilled water, and then left to dry.

A third and simpler method used to graft carboxyl groups onto the surface of the CNF was
conducted in the reaction chamber of the CVD equipment. 20 mg of NMBs was heated to 400 C
in dry air for 30 minutes after which it was allowed to cool.

2.4.4 Characterization
Scanning electron microscopy (SEM) was carried out to observe the morphology of the four
different NMBS samples. These are the as fabricated, HNO3 treated, HNO3/H2SO4 treated and air
oxidized samples. Characterization was performed using an FEI Quanta 3D FEG Dual Beam
FIB/SEM with an xT Microscope Control Software. Images were recorded with an accelerating
voltage of 5 kV by placing samples on a double sided copper tape and attaching it to a stand.

The Nicolet 6700 with OMNIC software was used for the Fourier transformed infrared
spectroscopy (FTIR) characterization to determine the successful carboxyl functionalization of the
CNFs. Samples were loaded onto an ATR sample holder for analyses. The surface chemical
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bonding and structure of all four samples analyzed were obtained in the frequency range of 600 –
4000 cm-1.

The Renishaw 2000 Micro-Raman was used for the Raman studies of the as-fabricated CNF. The
presence of defective graphitic sheets was obtained in the frequency range of 1000 – 2500 cm-1.

2.5

Results and Discussions

2.5.1 Catalyst Layer Formation
The three stage flow mechanism employed for the ELD process is shown in Figure 2.3. The
functionalization stage introduces the amine group onto the surface of the MBs which is
subsequently activated by the adsorption of Pd(II). The final deposition results in a color change
of the glass spheres due to the uniform layer of nickel coating deposited on the glass surface. Figure
2.4 shows images of MB, nickel coated MB, and NMBs. Figure 2.5 shows an SEM micrograph of
the nickel coated MB and a typical optical micrograph of the nickel coated MBs formed on silicon
wafer [102]. The FTIR spectra of as-received MBs and ELD nickel coated MBs are shown in
Figure 2.6. Similar spectra were obtained for both samples. The spectra composed mainly of the
broad absorption bands at ~700 – 1000 cm-1 corresponding to the S-O stretching vibrations. The
bands at ~1405 corresponds to the O-H bends respectively [103]. The peaks at ~2364 cm-1 can be
associated with the O-H stretch from strongly hydrogen-bonded –COOH [104]. The nickel coating
therefore did not contribute any functional groups to the surface since they only acted as nucleation
sites for the growth of the CNF.
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Flow mechanism of electroless nickel deposition on glass microballoon.

Figure 2.4
Images of as-received microballoons, microballoons after electroless nickel
deposition, and carbon nanofiber grown on nickel coated microballoons.
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Figure 2.5
(a) SEM micrograph of nickel coated MBs and (b) typical optical micrograph of a
layer of nickel coated MBs formed on silicon wafer [102].
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Figure 2.6

FTIR spectra of (a) as received MB and (b) nickel coated MB.

Nonmetallic substrates like glass microballoons lack the catalytic properties required for CNF
growth as well as forming a strong bond with the CNF synthesized on their surfaces. This is
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achieved by coating the surface of our glass microballoons with nickel. The presence of hydroxyl
groups on the surface of glass makes them easily amenable to surface modification. These silanol
functional groups, Si-OH, bonds strongly with amino groups, such as APTMS, to form the stable
siloxane bond, Si-O-Si as a result of the partial protonation of the APTMS. This has been reported
to uniformly coat the surface of the glass while the amine group protrudes outwards serving as
active sites on the glass surface for binding with other molecules [105, 106]. However, these amine
groups have low affinity for nickel hence the use of Pd (II) as catalyst. This is reduced by the
presence of H2PO2¯ to form Pd which is strongly bonded to underlying siloxane layer. These Pd
particles act as seeds for the nickel deposition process resulting in the almost uniform nickel
coating of the surface of the MB.

2.5.2 CNF Growth
Figure 2.7 shows the SEM micrographs of CNFs grown on the MB at two different magnifications.
The nickel layer formed on the MB acted as nucleation sites and growth for the CNFs. This ensured
that the CNFs are connected to the MB along their axial direction, which is essential in building
efficient charge and load transfer interfaces. The micron dimension of the spheres also allows the
uniform and randomly oriented growth of several CNFs on each MB as shown in Figure 2.7.
Average CNF diameters of 40 nm with high CNF density on each MB were fabricated using this
process. Figure 2.8 shows the Raman spectra of the as fabricated CNFs [102]. Defective graphitic
sheets are always present in fabricated CNFs and this was confirmed by the D-band observed at
1325 cm-1 in the Raman spectra.
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Figure 2.7

(a), (b) SEM micrographs of as-fabricated NMBs at different magnifications.
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Figure 2.8

Raman spectra of as-fabricated CNFs [102].

Gases such as methane, acetylene, xylene, ethylene, and carbon monoxide have all been used in
the fabrication of CNFs with varying advantages of each of these carbon sources [107]. The use
of C2H2 as the source of carbon for the growth was chosen due to its higher decomposition rates
even at the 650 C used in fabrication. C2H2 also can be used in the absence of NH3 as NH3 have
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been reported to suppress the CNF growth due to its enhanced etching effect [107]. The use of
hydrogen influenced the decomposition of the nickel precursors and C2H2, avoided the formation
of amorphous carbon on the surface of the nickel catalyst and also acted as a carrier gas. The use
of water vapor, a weak oxidizer, selectively removed amorphous carbon deposits thereby
preventing the coating of the catalyst particles and hence improving the CNF growth. Argon gas
acted as the major carrier gas in the system while maintaining a neutral environment in the chamber
[108].

From the fabrication parameters, the length of the CNFs, evident in Figure 2.4 (b), curved with
irregular wave shapes due to the surrounding neighboring particles as the CNF length increased.
This is consistent with the report published by Zhang et al. regarding the increase of the branched
length of CNF with growth time progressively in a quasi linear manner [49]. This type of structure,
compared to the vertically aligned, is more desirable for applications in biosensing devices as more
outer CNFs surfaces are made available for conjugation with biomolecules which can easily be
immobilized on capture substrates.

2.5.3 Surface Functionalization Results
The fabrication process used in CNF growth results in the deposition of varying amounts of
oxidized carbonaceous fragments. Coupled with the inert nature of the sidewalls of the CNFs, a
combination of acidic and basic solvents were used in the functionalization of the CNF. The
schematic modification of the CNF using HNO3 as an example is shown in Figure 2.9. Acidic
oxidation most often results in the oxidation of the carbonaceous fragments and this was avoided
by washing with NaOH before oxidizing again with the dilute form of the acid used in oxidation.
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SEM micrographs of the three oxidation methods used are shown in Figure 2.7 (a) – (d) while the
combination of acidic effect and the several washing resulting in the fracturing and peeling off of
the CNFs from the MBs are shown in Figure 2.7 (d).

Figure 2.9
The modification process of CNFs by HNO3 treatment. Carbonaceous fragments
are represented by red wavy lines. Similar processes are found elsewhere [88].

The acid oxidation is a more selective technique that removes amorphous carbons and contaminant
metals; however, its effect can be seen in the SEM micrographs. The concentrated nature of these
acids resulted in the shortening of the CNFs on the MBs and increase number of surface defects
with the HNO3/H2SO4 combination having the most pronounced effect. This is consistent with
findings by several researchers [48, 86-88, 109]. The interaction between the graphene layers of
the CNFs and these concentrated acids have been investigated by Collins [110]. His findings
indicate that these highly oxidative acids do not continuously etch the graphene’s sidewalls due to
their inert nature but instead covalently add to its edges and basal planes resulting in adduct defects
which continuously etch off these planes with time. This is responsible for the loss of structure in
the acidic functionalization with the stronger HNO3/H2SO4 combination having a more adverse
effect, Figure 2.10.
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Figure 2.10 SEM micrographs of (a) air oxidized, (b) HNO3 oxidized, (c) HNO3/H2SO4, and
(d) fractured and peeled off CNFs from acidic oxidization of MBs.

Oxidation in air tends to have a harsher purification scheme at temperatures between 400 C and
750 C. At the low end of this temperature range, amorphous carbon has been reported to rapidly
convert to CO2 through cooperative reactions with oxygen and water vapor [110]. The graphitic
carbons do burn more slowly, since only the carbon atoms on the edges of the graphene are
reactive. Therefore, at 400 C oxidation temperature, the fraction of graphitic impurities on the
CNFs surfaces will oxidize faster along their sidewalls than the edges of the graphene. This is
responsible for the better retained structure of the NMBs after oxidation.
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Figure 2.11 shows the dispersed states of the three different types of oxidized NMBs in water, at
the moment of dispersion and approximately 2 mins and 10 mins thereafter. When a surface is
oxidized, ionic charged functional groups are introduction onto its surface. In this study, negatively
charged carboxyl and hydroxyl groups are chemically introduce onto the surface. These charged
groups initially enables the CNFs to repel each other in the water solution, and hence their initial
good dispersion. Suspension stability reduces drastically with time with HNO3 having the worst
stability among the three groups as shown in Figure 2.11 (b) after only 2 minutes of suspension.
After 10 minutes, most of the NMBs are seen to settle for both the HNO3/H2SO4 and air oxidized
with the air oxidized having the better stability. During settling, a portion of the NMBs were seen
to settle at the bottom of the tube with the remaining floating on the water.

The air oxidized had the best stability with HNO3 oxidized having the worst. However, the long
term solubility of all oxidized samples was very poor. The difference in solubility can be attributed
to the efficiency in functionalization with HNO3 having the least number of functionalized groups
and air oxidized having the most.

Figure 2.12 shows the FTIR spectra of the as fabricated and the three different oxidized NMBs.
The introduction of the infrared radiation onto the samples led to a difference in charge state
between the carbon atoms which induced the formation of an electric dipole leading to signal
generation. The frequency of adsorption is a function of the stretch and bending functional group.
Weak signals were generated due to the weak difference of charge state between the carbon atoms
leading to a silent spectrum. All four samples presented similar signals with the exception of the
~2359 cm-1 peak in the acidic oxidized samples. This peak is from the characteristic disruption of
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the quaternary ammonium (C=N+) formed as a result of the presence of nitrogen in the fabrication
environment [111]. The acidic oxidants reacts with this functional group, hence the absence of this
peak in the acidic oxidized.

(a)

(b)

(c)

Figure 2.11 Dispersion of NMBs in PBS after modification with HNO3, HNO3/H2SO4, and air
(from left to right). All solutions have 1 mg/ml concentration of NMBs and at times (a) just
dispersed, (b) 2 minutes, and (c) 10 minutes.
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Figure 2.12 FTIR Spectra of as-fabricated and the different types of surface oxidized samples
used in the research.

Weak signals were also generated at ~3666 cm-1 characteristic of stretching vibrations of O-H
bonds preferentially from the hydroxyl groups. The appearance of peaks at ~1000 – 1100 cm-1 for
all the samples correspond to the C-O stretching indicating the presence of the carboxyl groups.
The presence of these functional groups which was confirmed from the FTIR results agrees with
the observed stability of these samples in water. These functional groups reduced the van der Waals
interactions between the individual NMBs leading to an improvement in their dispersion stability
in the aqueous media.

2.6

Summary

In summary, fabrication of CNFs on glass microballoons has been achieved using a classical CVD
process. This was made possible by uniformly coating the MBs with nickel using a three stage
process: functionalization, activation and deposition techniques. The presence of amorphous
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carbonaceous fragments requires further purification techniques. These techniques result in the
production of cleaner materials as well as the introduction of functional groups making it easier
for further processing of the CNFs. FTIR studies showed the presence of the hydroxyl and carboxyl
functional groups on the as fabricated CNFs. The three different purification methods employed
in this study also showed the presence of the hydroxyl and carboxyl functional groups. However,
the acid modified surfaces resulted in the substantial loss of CNF structure while the air oxidized
NMBs maintained its CNF structure. The other major drawback in the use of the acidic oxidants
is their effect on downstream processes. These chemicals are not environmentally friendly and
may affect applications in biosensing and other acid sensitive uses. The air oxidized CNFs
therefore stands out as the ideal surface treatment method for attaching the hydroxyl and carboxyl
functional groups needed for biosensing applications.
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CHAPTER 3
IMMUNOASSAY ON GLASS SLIDE USING CARBON NANOFIBERS GROWN ON
GLASS MICROBALLOONS (NMBs)
3.1

Introduction

Disease diagnostics continues to play a major role in the healthcare sector. It is regarded as an
attempt at classifying an individual’s condition into separate and distinct categories that allow
medical decisions about treatment and prognosis to be made. Several methods have been used in
diagnostics. These methods include clinical, laboratory, radiology, retrospective, and
immunoassay diagnoses. Technological advances have led to rapid improvements in most of these
techniques with immunoassays being no exception.

Immunoassays provide quick and accurate tests that are widely used for on-site and laboratory
diagnosis of various diseases. It is a valuable analytical technique based on molecular recognition
between antibodies and antigens that allows for detection with high sensitivity and specificity.
They have been widely used for the identification and quantification of target molecules in
applications such as clinical diagnostics, proteomics, pharmaceutical research, environmental
analysis and basic biological investigations [112, 113]. The high specificity of the antibody/antigen
interaction enables the relevant analyte to be isolated from complex mixtures with minimal sample
preparation while being relatively inexpensive and providing exceptionally low detection limits
[113].

The high specificity of the antibody/antigen interaction makes their immobilization on any support
a vital process. The ideal support should robustly attach all the chosen biological species in an
appropriate orientation without altering their conformation. Attachment has been a challenge on
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different substrates due to the variety in the polarities, hydrophobicities, charges, sizes, and
structures of different biological species while repelling nonspecific binding. Successful
immobilizations have however been achieved on substrate materials such as those made from
silicon, glass, and polymers [12, 114-119]. The need for less sample/reagent consumption, a
reduced risk of contamination, enhanced sensitivity, low unit cost, lower power consumption, and
a higher reliability led to the use of microfluidic devices for immobilization [113].

Silicon and polymeric materials such as polydimethylsiloxane (PDMS) are materials commonly
used for the fabrication of these microfluidic systems. As a result, various protocols have been
developed for immobilizing various biological species on these substrates. The presence of bubbles
and dead volumes continue to hinder the full scale utilization of silicon in microfluidic devices.
With PDMS, hydrophobic surface and nonspecific adsorption of proteins and other molecules have
constituted their major limitation [118]. The optically transparency of glass throughout the visible
spectrum, the ability to easily functionalize the surface of glass, and the recent low cost of
fabricating glass-based microfluidic chips has played a role in its continued use as a substrate in
immobilization [119]. An added advantage is their ability to offer higher density arrays and the
use of lower sample volumes. New materials such as paper and cotton thread have recently also
been introduced as simple and low-cost platforms for immobilizing biological species [112, 120,
121].

Labeling biological species has always been a challenge. Labeling on their antigenic epitopes
result in the loss of their interlocking ability with affinity reagents, hence their structure and label
location need to be understood. Various labels, including fluorescent substrates, enzymes, redox
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molecules, and metal/semiconductor particles, are utilized and these play a key role in signal
generation [122]. Other immunosensors do also employ label-free detection where the amount of
target antigen is quantified by physical and chemical changes arising from target antigen capture
on the sensing surface [123]. Sensitive detection still remains one of the main challenges facing
clinical diagnostics in the early stages of disease. Extensive research on the use of other labels,
such as CNTs, with better signal detection capabilities is currently ongoing [28-32, 124].

Physical adsorption and chemical modification are the two strategies used in the application of
biological species onto various substrates. The physical adsorption (interaction) technique takes
advantage of non-covalent interactions such as van der Waals forces, hydrogen bonding, and
hydrophobic interactions between the species and the substrates [125]. The adsorbed species are
usually randomly oriented, forming a heterogeneous surface, which usually lead to low surface
density, reduced activity, may prevent analyte binding, and lead to irreproducibility of results.
Adsorption processes do cause some species also to denature and are subsequently inactive upon
direct contact with the substrate. Finally, due to the weak attractive forces, attached species may
easily be washed away during the numerous washing stages and at the same time while also
causing the reversibility of the adsorption process [126].

The covalent attachment protocol relies on the formation of covalent bond between a functional
group on the substrate and an exposed group on the species. The substrates may be functionalized
with a variety of chemical groups such as NH2¯, SH¯, COOH¯, NHS ester and epoxide groups
[127]. Substrates with functional groups such as the amine only adsorb proteins via electrostatic
interactions but this can be made to change to the aldehyde surface by exposing it to
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glutaraldehyde, a crosslinking agent [128]. The presence of these functional groups on all parts of
the antibody as well makes it easier for covalent bonding to be achieved in a random orientation
[129].

3.2

Antibodies as Recognition Elements

The extraordinary properties of carbon nanomaterials have led to increasing research into their
possible use in various applications. Investigation into their use in the detection of biomolecules
and other medical related applications continues to attract a lot more interest [24, 31, 74, 86, 120,
130]. CNFs in this study are used as labels with the detection mechanism mainly based on the
antigen-antibody interaction. Since the mid-1990s, antibodies have become an important class of
drugs, with more than 28 antibodies approved for therapeutic and diagnostic use in the US and
Europe [131]. Initially, the approved antibodies were based on mouse (immunoglobulin G) IgG or
chimeric IgG with those based on humanized or fully human IgG sequences entering the market
most recently.

Immunoglobulin (Ig), also known as antibodies, are large Y-shaped protein produced by B-cells
that are used by the immune system to identify and neutralize foreign objects such as bacteria and
viruses. IgG is a major effector molecule and accounts for about 75% of the total Ig in plasma of
healthy animals including humans. IgM, IgA, IgD and IgE accounts for the remaining 25% with
each of them having a characteristic property and function. Human IgG has a molecular weight of
~150 kDa and is secreted by specialized B lymphocytes known as plasma cells. Antibodies display
an extraordinary specificity and binding affinity for antigens in nature. Each antibody has a unique
structure recognized by a corresponding antigen in a lock-and-key mechanism. This mechanism
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makes them useful as analytical reagents in diagnostics, in environmental and food tests, and in
many other uses [132].

IgG has a structure made up of three protein domains as shown in Figure 3.1. Two identical
domains make up the arms of the Y-shape structure and are known as “Fab”, fragment, domains
in which each arm contains a site that can bind to an antigen, making IgG bivalent molecules. The
third domain forms the base of the Y-shape and it is known as “Fc”, fragment that crystallizes.
The Fab segments are linked to the Fc by the hinge region, which varies in length and flexibility
in the different antibody classes and isotypes [133]. This segment allows lateral and rotational
movement of the two antigen binding domains. The two heavy-chain polypeptides in the Y
structure are identical of about 50 kDa, and the carboxyl-terminal regions of the two chain fold
together to make the Fc domain. The two light chains are also identical with a molecular weight
of about 25 kDa. All, polypeptide chains are held together by disulfide bridges and non-covalent
bonds [133]. The presence of several different functional groups on all parts of the antibody makes
it easier for covalent bonding to be achieved in a random orientation with other substances [129].

Two groups of antibodies, polyclonal and monoclonal, have been classified based on their
specificity against a given antigen. Polyclonal antibodies are produced by immunizing animals
such as chicken, mouse or rabbit with an antigen and adjuvant preparation. The animal’s immune
system is stimulated to produce B cells which secrete antibody that is specific for the antigen.
These are extracted from the animal antiserum and purified to the desired level. Polyclonal
antibody are prepared usually by mixing antibodies of different specificities making them bind
with different strengths to different epitopes on the same antigen. The production process is
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relatively inexpensive, universal and large quantities of an antibody can be isolated from a single
extraction. They are able to withstand greater variation in temperature and pH and are used to
confer passive immunity to certain diseases [134].

Figure 3.1

Schematic structure of IgG [135].

Monoclonal antibodies are identical because they are produced by specialized cells which have
been cloned. Currently, this type of antibodies is only produced in mice. They are obtained by
collecting cells from the spleen of a mouse exposed to an antigen. These cells are cultured with
cells from a myeloma, a cancer of the plasma cells, to create a hybridoma which will endlessly
replicate itself. Tested cells from the hybridoma with the desired antibodies are cloned and used
to develop a large store of monoclonal antibodies. These antibodies are pure, making them superior
to polyclonal antibodies. A powerful feature of monoclonal antibodies is that the immortal nature
of the hybridoma allows for its continual reculturing, thus providing a constant source of
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monoclonal antibodies. Monoclonal antibodies bind to only one epitope of a given antigen, being
more specific than polyclonal antibodies [136].

3.3

Binding of Antibodies to Carbon Nanofibers

In order to fully recognize the potential of using CNFs as labels in biosensing devices, it is essential
to be able to attach biomolecules on to their surfaces. The two most used methods of attachment
of biological species to CNFs are the adsorption and covalent attachment methods. Physical
adsorption is the simplest method of binding in which biomolecules are mechanically attached on
to the surface with the help of van der Waals forces. It involves applying a buffer solution
containing the biological molecule on to the CNF. Due to the high aspect ratio and the
hydrophobicity nature of the CNF, the applied biological molecule is easily adsorbed to the CNF.
Protein surfaces with high degree of hydrophobicity display a stronger affinity to the CNF surface.
Suresh et al. [137] have reported a high amount of ricin adsorption on MWCNT compared to
graphite paste electrodes using physical adsorption.

Covalent attachment involves the formation of covalent chemical bonds between the biomolecules
and the CNFs. The best stability, accessibility and selectivity can be achieved through this type of
bonding due to its capability of controlling the location of the biomolecules. Chemical bond
formation requires the reaction between functional groups on the surfaces of both the CNFs and
the biomolecules. Functionalization of the CNFs is always performed prior to immobilization. The
carboxyl acid group is often the best choice because it can undergo a variety of reactions and is
easily formed on carbon nanotubes via oxidizing treatments. The control of reactants and/or
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reaction conditions may control the locations and density of the carboxyl groups on the nanotubes
which can be used for controlled attachment of biomolecules.

The presence of large amounts of both amine and carboxyl acid groups on their surface of proteins
can lead to undesirable side reactions of intermolecular conjugation of proteins and CNFs [138].
This intermolecular connection can be avoided by using a two-step process where the carboxyl
acid groups on the CNFs are first reacted with the water soluble 1-ethyl-3-(3dimethylaminopropyl) carbodiimide hydrochloride (EDC). This converts it to active esters surface
functionalities and the addition of Nhydroxysulfosuccinimide (sulfo-NHS), another water soluble
compound, increases the solubility and stability of the intermediate. The resulting product reacts
with the primary amine functional group on the surfaces of the biomolecules to form very strong
amide bonds as shown in Figure 3.2 [127]. Thus, the process can guarantee homogenous
attachment of proteins onto carbon nanotubes.

Figure 3.2
Reaction of the carboxylate functional group with a primary amine containing
molecule, in the presence of EDC and sulfo-NHS [139].
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Abera and Choi have reported the covalent immobilization of the protein molecules on MWCNT
via the two-step EDC and sulfo-NHS coupling chemistry [140]. They chemically bonded human
IgG to carboxyl acid functionalized MWCNT through the two step coupling chemistry [141]. Their
process avoided the intermolecular conjugation of proteins, and guaranteed the uniform attachment
of the IgG on the MWCNT. Lerner et al. have also been able to use the two –step approach to treat
SWCNT and used the treated CNTs to rapidly detect very low concentrations of Lyme disease
antigens [142]. Covalent attachments, however, do provide good stability between the antibodies
and the CNFs and also better binding selectivity due to their ability to directly control the location
of the antibody [143]. However, their electronic and mechanical properties are negatively affected.

3.4

Blocking as a Means of Preventing Non-Specific Binding

Biological samples are complex in nature containing numerous types of proteins and other
molecules. Non-specific binding (NSB) of undesired molecules from a sample is a major obstacle
in the development of biosensors. NSB becomes a major issue when incorporating carbon
nanomaterials into biosensors. CNFs have a high chemical affinity for biomolecules and end up
binding with unwanted molecules as well. As a result, the generated signal are not proportional to
the analyte concentration. NSB can therefore increase detection limits and degrade sensitivity.
Minimizing protein NSB have been achieved by using specific molecular receptors. The receptors
cover the gaps on the CNFs wall left unprotected by the immobilized protein with specific blocking
agents [141, 144, 145].

NSB, mainly by the spontaneous adsorption of the protein, to the nanostructure surface is usually
attributed to hydrophobic interactions between the protein and the nanotube surface. Various
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surfactants including polyvinylpyrrolidone (PVP), Tween 20 and polyethylene glycol (PEG) have
been used in reducing this type of NSB. All these three surfactants display protein-resistant
properties. Successful modification of the surface of MWCNTs has been achieved with PVP
enabling the uniform dispersion of the MWCNTs in aqueous solutions [141]. Hasan et al. have
also reported the dramatic improvement in the stability of SWCNT in N-methyl-2-pyrrolidone
solution by PVP. In addition, their SWCNTs spontaneously debundled some nanotube aggregates,
increasing the isolated SWCNT population without any further ultrasonic treatment [146]. The
improvement in the dispersion was attributed to the wrapping and twisting of the PVP polymer
around the CNT centers through their flexible or semi-flexible backbones [147].

Tween 20 contains a long alkyl chain of twelve carbons with twenty ethylene glycol and three
terminal hydroxyl groups. It has been reported that a Tween 20 coated semiconducting nanotube
device did not show any changes in conductance upon exposure to various types and
concentrations of protein solutions. The surfactant was found to strongly adsorb onto the CNT
surface forming a nearly uniform layer by favorable hydrophobic interactions which imparted a
high protein resistance [148]. PEG has also been adsorbed onto the surface of CNTs where it acts
as an effective barrier against nonspecific protein adsorption by forming a highly hydrophilic,
neutrally charged, sterically hindering layer at the surface.

Shim et al. (40) found the coadsorption of Triton and PEG on SWCNTs to be highly effective in
preventing nonspecific adsorption of streptavidin to nanotubes [149]. The adsorption of PEG on
the surface of MWCNTs has also been reported to improve the dispersion of MWCNTs in aqueous
solutions [141]. In the case of PEG, the adsorption mechanism of NSB onto the surface of the CNT
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is less understood. However, a brush-induced steric repulsion preventing contact between proteins
and the underlying surface, and the hydration shells around the PEG moieties, has been proposed
as the dominant mechanism for their adsorption [150].

3.5

Detection Principle

3.5.1 Biomolecule – NMBs Conjugation
The use of both competitive and sandwich protocol in disease detection has been studied.
Sandwich immunoassay format is preferred in RDTs devices because samples do not have to be
purified before analysis. The schematic of the fluorescence studies for the sandwich format is
shown in Figure 3.3. CNFs are grown on glass microballoons (NMBs) and initially conjugated to
the primary antibodies. The NMBs are further immersed in a solution containing the desired
antigens. The antigens are interlocked by the primary antibodies after which the NMBs are then
immersed in a solution containing secondary antibodies coupled to fluorescein isothiocyanate
isomer I (FITC). Further interlocking between the antigens and the secondary antibodies occur
leading to the formation of a strong bond between the NMBs and the biomolecules.

Figure 3.3

Schematic of the processing stages of a sandwich immunoassay protocol.
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3.5.2 NMBs Immobilization on Glass Slide
The schematic of the NMBs immobilization process on glass substrate using the sandwich
immunoassay protocol is demonstrated in Figure 3.4. The sandwich protocol is used in RDTs due
to its high specificity resulting from the use of two antibodies [151]. This sandwich protocol is
also suitable for analyzing complex samples and provides high flexibility and sensitivity. All
antibodies are designated as Y in Figure 3.4. NMBs {shown in Figure 3.4 (a)} are initially
conjugated with secondary antibodies {Figure 3.4 (b)}. Primary antibodies, however, are
immobilized on the capture zone of the glass slide as shown in Figure 3.4 (c). Antigens are locked
by the immobilized primary antibodies when PBS/antigen suspension was passed through the
capture zone {Figure 3.4 (d)}. NMBs in Figure 3.4 (b) were then flowed through the capture zone
in Figure 3.4 (d) with captured antigens interlocking with the secondary antibodies on the NMBs
as shown in Figure 3.4 (e).

Figure 3.4
Schematic of the capture procedure of NMBs on glass slide. (a) NMBs, (b)
secondary anti-IgG conjugated NMBs, (c) primary IgG immobilized on glass slide, (d) anti-IgG
locked by immobilized primary IgG, (e) immobilized NMBs on slide, and (f) signal detection
setup.

The binding of primary and secondary antibodies with antigens gives a visibly dark signal at the
capture zone. Electrical resistivity measurements can be conducted at the capture zone {Figure 3.4
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(f)} and the generated electrical signal will vary with the antigen concentration. Increasing the
antigen concentrations will result in increasing density of NMBs being immobilized at the capture
zone as depicted in Figure 3.5. As a result, the capture zone becomes darker while the resistivity
of the zone reduces accordingly.

Figure 3.5
zone.

3.6

Schematic of increasing anti-IgG concentrations on NMBs network at the capture

Experimental Procedures

Air oxidized NMBs samples were used for all tests. 4-morpholinoeethanesulfonic acid (MES) and
polyethylene glycol solution (PEG) (MW 8000) purchased from Sigma-Aldrich, GA, USA and
phosphate buffered saline 1X solution (PBS), 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide
hydrochloride (EDC) and N-hydroxysulfosuccinimide (Sulfo-NHS) obtained from Thermo Fisher
Scientific, IL, USA were used in the immobilization process. Fluorescein isothiocyanate isomer I
(FITC), purified immunoglobulin G (IgG, 4.7 mg/ml) from human serum, anti-human IgG (10.2
mg/ml) antibody produced in goat, anti-goat IgG-FITC (15.4 mg/ml) produced in rabbit, and
sodium borohydride were obtained from Sigma-Aldrich, MO, USA. All biomolecule contained
samples were obtained in a solution of 0.01 M PBS, pH 7.4 and containing 15 mM of sodium
azide. A marathon 8K centrifuge was used.
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3.6.1 Blocking
PEG was used as the surfactant for non-covalent functionalization of the NMBs in this study. Its
use has been reported to prevent NSB [140]. For all blocking procedures, 2 mg of NMBs was
dissolved in 5 ml of PEG and 5 ml of PBS. The suspension was mildly swirled for 6 hours. Dilution
with PBS, centrifugation at 2000 rpm for 3 minutes and subsequent filtration were performed to
obtain the PEG covered NMBs filtrate. Further washing with PBS was done to completely remove
all unbound PEG. The PEG coating prevents nonspecific binding (NSB) of unwanted proteins to
the NMBs.

3.6.2 Functionalization of NMBs with EDC/Sulfo-NHS
The covalent immobilization of the biomolecules to the carboxyl groups of the NMBs was
performed using a modified EDC/Sulfo-NHS chemistry [141]. 5 ml, pH 6.0 solution of 0.2 M EDC
and 0.1 M Sulfo-NHS was prepared in MES solution. 2 mg of NMBs were suspended in the
prepared solution. The suspension was mildly agitated for 2 hours at room temperature. The
carboxylated CNFs on the microballoons reacted with the EDC/Sulfo-NHS solution forming a
semi-stable amine-reactive Sulfo-NHS ester. The reaction process is shown in Figure 3.2. The
NMBs were recovered by centrifuging at 2000 rpm for 3 minutes followed by filtration. MES was
added and the centrifugation and filtration process repeated three times. This completely removes
excess EDC/Sulfo-NHS from the NMBs.

3.6.3 Biomolecule – NMBs Conjugation
Various protocols were studied using the fluorescence test. Firstly, the binding of both antigens
and antibodies tagged with FITC to NMBs were performed. Secondly, non-covalent
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functionalization with PEG was performed before the conjugation of NMBs to antibodies. Thirdly,
NSB was studied by conjugating excess anti-IgG to PEG treated NMBs. The filtrate was treated
further with anti-IgG-FITC. Competitive assay format was also tested. IgG conjugated to NMBs
was treated with anti-IgG-FITC. Finally, sandwich assay format was performed by treating IgG
conjugated to NMBs with anti-IgG.

The sandwich conjugation of antigens to the EDC/Sulfo-NHS treated NMBs samples was achieved
by adding a solution containing 1 ml of PBS and 100 µl of anti-IgG. The mixture was incubated
at room temperature and mildly agitated for 24 hours. Excess reactants were removed by washing
with PBS as described earlier. This conjugates primary IgG to the NMBs. PBS (1 ml) and antiIgG (100 µl of 1 ng/ml) was added to the NMBs that contains immobilized primary IgG and
incubated for 24 hours at room temperature to bind the anti-IgG with the IgG. Thorough washing
with PBS was performed to remove all unbound anti-IgG. The filtrate was again dissolved in 1 ml
PBS and 100 µl of secondary IgG-FITC. The solution was incubated at room temperature and
mildly swirled for 24 hours. Unbound IgG-FITC was removed by washing with PBS. The
sandwich interlocking of the IgG with anti-IgG was confirmed from fluorescence studies.

The effect of IgG concentration on its conjugation with NMBs was studied using four different
IgG concentrations. 1.6 mg of EDC/Sulfo-NHS treated NMBs dissolved in 5 ml of PBS was
prepared. To each solution, 20 µl of 0.001 ng/ml, 0.01 ng/ml, 1 ng/ml, and 10 ng/ml of IgG-FITC
was added. The solutions were left to stand for 24 hours after which they were centrifuged and
filtered. Three separate washings were performed on these samples using PBS and the obtained
filtrates used for fluorescence studies. Similar test was carried out using anti-IgG-FITC.
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3.6.4 Preparation of Immunosensor
Micro-glass slides used for the fabrication of the immunosensor were obtained from Corning, NY,
USA. Tween-20 purchased from Amresco, OH, USA, NaOH and H2O2 from Macron Chemicals,
PA, USA, and H2SO4 from Fisher Scientific, USA were used in the cleaning process. Anhydrous
toluene solution from Macron Chemicals, PA, USA, glutaraldehyde obtained from Sigma-Aldrich,
MO, USA, and 3-aminopropyltriethoxysilane (APTES) from Alfa Aesar Chemicals, MA, USA
were used in the amino functionalization of the glass slides.

Glass preparation and cleanliness are of critical importance in antibody immobilization. Glass
slides were cut into rectangular shapes (1 cm × 2.5 cm) and capture zones marked within the mid
portion of the slides. The slides were ultrasonicated in deionized water containing 2% Tween-20
by volume for an hour. The washed slides were thoroughly flushed in deionized water and
ultrasonicated again for an hour.

Surface modification of the glass with APTES reported by Tang et al. [115] and Tsutsumi et al
[116] were modified to suit our process. Slides were initially soaked in 1 M NaOH for 30 mins
and then rinsed with deionized water. Washed slides were soaked in piranha solution, 30% H2O2
and 70% H2SO4, at 80 C for 2 hours. They were thoroughly washed with deionized water,
followed by ethanol and acetone and dried for an hour at 110 C. The piranha solution roughens
the surface of the slides for subsequent immobilization procedures. Modification by immersing
slides in 5% APTES in anhydrous toluene solution for 10 mins proceeded immediately resulting
in the formation of amino groups on the surface of the glass slides. The slides were thoroughly
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rinsed with toluene and acetone before drying at 110 C for an hour. This removed completely
excess APTES and toluene solution.

Activation of the amino functionalized slide surfaces was achieved by immersing the slides in a
3% glutaraldehyde in PBS solution for an hour. The slides were thoroughly rinsed with ethanol
and deionized water to completely remove unreacted glutaraldehyde. Nitrogen gas was used to dry
the slides. Two treated slides were used for the immobilization processes. A solution made up of
50 µl of 1 mg/ml human IgG and 20 µl of glycerol was prepared and spotted on the capture zones
of both slides. The slides were left to incubate for an hour after which they were thoroughly washed
with PBS to remove unbound IgG. The slides were incubated in a 2% BSA and 0.05% Tween-20
in PBS solution for an hour. This blocks all sites from nonspecific binding. Slides were thoroughly
washed with 0.05% Tween-20 in PBS.

50 µl of 0.01 ng/ml of anti-IgG in PBS was applied onto the capture zone of the first slide. The
anti-IgG is expected to be captured by the immobilized human IgG on the slides. The slide was
allowed to incubate for 30 seconds after which it was thoroughly rinsed in PBS solution. 1 mg of
IgG conjugated NMBs were then suspended in 5 ml PBS solution. Both slides were dipped in the
NMBs/PBS solution for 30 seconds. The slides were carefully rinsed with PBS solution.
Immobilization of NMBs using anti-IgG concentrations of 0.1, 0.5, 1, 5, 10 and 50 ng/ml were
also studied. The presence of visible NMBs at the capture zones of the slides indicates the
successful detection of anti-IgG. Electrical resistance measurements were also performed on the
slides.
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Same treatment procedure was used for the immobilization of the NMBs on the glass slides.

3.6.5 Imaging
Scanning electron microscope (SEM) micrographs were obtained using an FEI Quanta 3D FEG
Dual Beam FIB/SEM and its xT Microscope Control Software.

Fluorescence studies was performed on samples using a Leica DM RXA2 fluorescence microscope
fitted with a 100× objective lens with a 1.4 N.A. Slidebook version 4.1 was used for image
acquisition from a Cooke SensiCam QE camera attached to the microscope. The FITC used in the
study incorporate excitation filters in the green (530 to 565 nm) spectral regions allowing the
detection of green emissions.

Optical images were obtained from an Axiovert 40 CFL inverted microscope fitted with a 20×
objective with a 1.0 N.A. AxioVision 4.6.1.0 was used for image acquisition from an AxioCam
MRc camera attached to the microscope.

Percentage area occupied by the NMBs on the glass slides were obtained using ImageJ 1.46r
software.

3.6.6 Electrical Measurements
A Lucas Labs Pro-4 four point resistivity system was used in obtaining resistivity measurements.
The system is made up of a Keithley 2400, a Pro4 and a notebook with a Pro4 V1.2.4 software
installed. The system uses the dual configuration test method of ASTM standard F84-99 to
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compensate for errors in probe spacing and errors caused by proximity to the edge of the
conducting layer. A V/I measurement was taken and recorded and the subsequent resistivity
computed.

3.7

Results and Discussion

3.7.1 EDC/Sulfo-NHS Functionalized NMBs
The use of EDC reagent acts as a crosslinker for the terminal –COOH groups on the ends of the
CNFs on the NMBs. This forms an inefficient amine reactive O-acylisourea intermediate that
dissociates rapidly regeneration of the carboxyl group. This makes it unstable and short-lived in
aqueous solutions. The addition of sulfo-NHS, in a two-step crosslinking procedure, results in the
formation of the semi-stable amine-reactive sulfo-NHS ester. This intermediate has sufficient
stability and bonds with the amine groups on proteins to form a very strong and stable amide bond
[152]. This reaction allows the carboxyl groups on proteins to remain unaltered [153].

The FTIR spectrum from the EDC/Sulfo NHIS treated NMBs show three additional peaks
compared to that of the as-fabricated. The spectra are shown in Figure 3.6. There was a weak signal
from the O-H stretching at ~2104 cm-1. A broader peak was created at 3100 – 3600 cm-1 and this
is attributed to vibrations of the hydroxyl (O=C-OH and C-OH) group [104]. The third peak
observed between 1470 – 1735 cm-1 is associated with the two amide bands of the semi-stable
intermediate. The amide band I is located at 1650 cm-1 (80% C=O stretch), the amide band II at
1550 cm-1 (60% N-H bend and 40% C-N stretch [103, 154]. The appearance of the amide bands I
and II indicates the successful functionalization of the carboxylated CNFs with the semi-stable
amine-reactive NHS ester.
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FTIR spectra of EDC/Sulfo NHS treated NMBs.

3.7.2 Non-Specific Binding
Proteins are made up of 20 amino acids groups that are either hydrophilic or hydrophobic, acidic
or basic in nature. This gives proteins a broader diversity in properties with each protein having
different individual functionalities [155]. As a result, proteins are physically and chemically
heterogeneous making them possess a three-dimensional structure that is critical to their function.
Proteins lose activity when they bound to solid surfaces and have been reported to absorb
nonspecifically to each other, to substrate materials, and to other proteins [156]. The variety of
polarities, hydrophobicities, charges, sizes, and structures, of proteins poses a challenge when
attaching different types of proteins to various substrates. This makes it difficult to achieve both
low nonspecific binding and high protein attachment.
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The stability of CNFs in buffer solutions and the elimination of NSB are critical prerequisites for
their use in biosensing applications. Results from this study show that a coating of PEG on the
NMBs reduces the duration for the particles to cluster {Figure 3.7} compared to that for the air
oxidized NMBs samples shown in Figure 2.11. The PEG chain completely wraps around the CNF
surface leading to its hydrophilic chaining extending into the aqueous phase, imparting water
solubility and biocompatibility. The presence of the hollow glass microballoons are responsible
for the eventual coalescence of the NMBs with time. Treatment with PEG also led to the saturation
of the free binding sites on the CNFs which resulted in the reduction of non-specific binding in
our study.

(b)

(a)

(c)

Figure 3.7
Dispersion of NMBs in PEG solution at times (a) just dispersed, (b) 10 minutes,
and (c) 20 minutes.

Figure 3.8 shows fluorescence micrographs of anti-IgG-FITC bound to NMBs (a) without PEG
and (b) with PEG. The covalent binding between the CNFs and proteins allowed for high stringent
binding conditions allowing weakly bound proteins to be washed away during subsequent
processes. Observance of fluorescence showed the successful conjugation of both IgG and antiIgG to the NMBs.
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PEG treated NMBs initially bound to excess anti-IgG and further conjugation with anti-IgG-FITC
showed no fluorescence { Figure 3.8 (c)}. This shows the achievement of complete passivation in
the use of PEG. Treating our NMBs with PEG
The
(b)
(a) will eliminate NSB in our conjugation process.
use of lower molecular weight PEG (below 5000 Da) have been reported not to efficiently prevent
non-specific protein adsorption, while longer linear PEG (molecular weights greater than 5000
Da) or branched PEG (molecular weight ~ 8000 Da) do prevent most interactions [157].

(b)

(a)

(c)

Figure 3.8
Fluorescence micrographs of anti-IgG-FITC bound to NMBs (a) without PEG and
(b) with PEG. (c) Fluorescence micrograph of PEG treated NMBs initially conjugated with excess
anti-IgG followed by treatment with anti-IgG-FITC.

The FTIR spectra of the NMBs coated PEG is shown in Figure 3.9. The spectra has similar peaks
to those observed after EDC/Sulfo-NHS treatment of the NMBs as shown in Figure 3.6. An extra
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broader peak is observed from 870 to 1130 cm-1 after the PEG treatment. Within this wavelength
region, strong C-O and Si-O stretching vibrations have been reported between 1000 to 1200 cm-1
[103, 158]. This region comprises of the typical vibration band of –Si-O-Si– at 1110 cm-1 and the
absorption band at 1115 cm-1 attributed to the characteristic –C-O-C– stretching vibration of the
repeated -O-CH2-CH2- units of the PEG backbone. Characteristic bands of the crystalline phase of
PEG have also been reported to be centered at 963 and 843 cm-1 [158]. The presence of this peak
indicating the functional groups associated with PEG further confirms the successful
functionalization of the NMBs with the NMBs.
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Figure 3.9

FTIR spectra of PEG modified EDC/Sulfo NHS treated NMBs.

3.7.3 Conjugation of Biomolecules to NMBs
Immunoassay is a laboratory technique that uses antibodies to capture molecules of the antigen
present in samples. Competitive immunoassay protocol is preferred in the detection of minute
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antigen concentrations in solution. Antigens that undergo this protocol usually have smaller sizes.
The small molecules have insufficient binding sites and are therefore unable to bind to two separate
antibodies. No secondary antibodies are used. Instead, a capture antibody is attached beforehand
to the surfaces of the immobilization material. Antigen (analyte) and a separate antigen molecules
conjugated to a label compete for the available antibody sites. The material is washed to remove
all unbound analyte and conjugate and substrate added. For enzyme labels, bound enzyme present
reacts with the substrate yielding color which inversely proportional to the concentration of the
analyte in the sample.

Other competitive assay formats have been used where antigen is initially immobilized on solid
material and antibody conjugated with label material introduced. For enzymatic labels, substrates
are added and captured conjugates yield color which are linearly proportional to the concentration
of the captured conjugates.

The use of NMBs as label in a competitive immunoassay protocol was performed. IgG was first
immobilized on NMBs. Treatment of the NMBs with varying concentrations of anti-IgG-FITC
was studied with the fluorescence microscope. Fluorescence was not observed in the sample
treated with 2 pg/ml of anti-IgG-FITC. The interlocking of the IgG with anti-IgG for the remaining
three samples was confirmed with fluorescence images being generated for those samples {Figure
3.10}. Similar studies was performed on NMBs conjugated with anti-IgG treated with varying
concentration of IgG-FITC. Fluorescence imaging indicated successful interlocking of IgG with
anti-IgG for concentrations of 0.01 ng/ml of IgG-FITC and greater as shown in Figure 3.11.

57

The competitive interlocking of anti-IgG and anti-IgG-FITC with IgG was also studied. Varying
the anti-IgG concentrations led to fluorescence being observed on samples treated with 0.01 ng/ml
and 1 ng/ml of anti-IgG {shown in Figure 3.12 (a) and (b)}. No fluorescence was observed on the
NMBs sample treated with 50 ng/ml of anti-IgG. Low concentrations of the anti-IgG led to fewer
interlocking with the primary IgG. Free IgG were therefore still available for binding. Addition of
the anti-IgG-FITC resulted in their equivalent number being able to bind with the available free
IgG. As the concentration of the anti-IgG increases, the number of free IgG reduces to a point were
all free IgG get consumed. Absence of free IgG leads to the washing off of anti-IgG-FITC, which
indicates no bonding and hence the absence in the fluorescence imaging for higher concentrations
(as shown in Figure 3.12 (c)).

(a)

(b)

(c)

Figure 3.10 Fluorescence micrographs of NMBs conjugated with IgG and further treated with
(a) 0.01 ng/ml, (b) 1 ng/ml, and (c) 10 ng/ml of anti-IgG-FITC.

(b)

(a)

(c)

Figure 3.11 Fluorescence micrographs of NMBs conjugated with anti-IgG and further treated
with (a) 0.01 ng/ml, (b) 1 ng/ml, and (c) 10 ng/ml of IgG-FITC.
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The sandwich protocol is a more efficient method of sample antigen detection. Samples do not
have to be purified before analysis while providing relatively higher sensitivity in comparison with
the competitive format. This method quantifies antigens between two layers of antibodies (i.e.
capture and detection antibody). The antigen must contain at least two antigenic epitope capable
of binding to antibody. Either monoclonal or polyclonal antibodies are used. The monoclonal
antibodies recognize a single epitope and allows fine detection and quantification of small
differences in antigen. Polyclonal, on the other hand, is used as the capture antibody to pull down
as much of the antigen as possible.

(b)

(a)

(c)

Figure 3.12 Fluorescence micrographs of NMBs conjugated with IgG. The NMBs were then
treated with varying anti-IgG concentrations followed by anti-IgG-FITC (a) 0.01 ng/ml, (b) 1
ng/ml, and (c) 50 ng/ml of anti-IgG.
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The use of NMBs as label in a sandwich immunoassay protocol was performed. Monoclonal and
polyclonal IgG and anti-IgG were used. Successful interlocking of the biomolecules was observed
from the fluorescence imaging as shown in Figure 3.13.

Figure 3.13. Fluorescence micrograph showing sandwich conjugation of IgG/anti-IgG/IgGFITC on NMBs.

3.7.4 Immunosensor
Various sensing mechanisms are being used in immunosensors. The use of CNTs/CNFs allow
sensing to be achieved through optical and/or electrical means with several demonstrations been
reported [30-32, 78, 138, 141, 142, 159, 160]. The electrochemical methods are highly attractive
due to their simplicity and relative ease of calibration while allowing quantification to be made
[159]. Currently, optical sensing is the only method being used in RDTs. This study demonstrates
the use of both optical and electrical sensing in RDTS.

Plain glass slides have been reported to exhibit a high degree of protein immobilization [161]. The
cleaning and roughening of the glass slides prior to any biological immobilization process is a
necessary step in getting rid of all residual organic contaminants which would otherwise interfere
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with the subsequent silanization procedure. The use of piranha solution in the cleaning process, in
our case, has been reported to introduce hydrophilicity to the surface of the glass slides as well as
maximizing the number of carboxyl groups [162].

Biomolecules are very diverse in nature possessing several carboxyl and amine groups. The use of
competitive immunoassays techniques in immobilizing biomolecules onto glass substrates poses
a great challenge. This technique permits signal amplification, however, recognition antigens that
are in low abundance must compete with more abundant proteins for immobilization on the glass
substrates. The sandwich format differs by being highly specific while permitting cross reactivity
of the antigens with two different antibodies. This makes them ideal formats for detecting disease
causing antigens and has therefore been adopted for use in RDTs devices.

Sandwich immobilization of NMBs on glass slide was achieved by using primary IgG, secondary
IgG labeled with NMBs and varying concentrations of 0.002, 0.004, 0.006, 0.008, 0.01, 0.1, 0.5,
1, 5, 10 and 50 ng/ml of anti-IgG. Successful detection of anti-IgG on the capture zones of the
glass slides were achieved within one minute. This was detected by observing visible network of
NMBs on the capture zone {Figure 3.14}. Increasing the anti-IgG concentration increased the
density of the NMBs as depicted in the optical micrographs shown in Figure 3.15 for some antiIgG concentrations. A linear relationship between the number of immobilized NMBs and anti-IgG
concentrations was observed as shown in Figure 3.16.
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Figure 3.14 NMBs immobilized on glass substrate using the sandwich format for IgG and antiIgG biomolecules.

(a)

(a)(b)

(c)

(d)(d)

Figure 3.15 Optical micrographs showing NMBs captured on glass slides in a sandwich assay
format with (a) 1, (b) 5, (c) 10, and (d) 50 ng/ml of anti-IgG concentrations.
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Figure 3.16 Variation of percent area of the capture zone covered with NMBs against anti-IgG
concentrations.

The use of the four-point probe method for electrical measurements helps in eliminating the
impedance contribution of the wiring and contact resistances. In this study, the use of CNTs as
label in the detection of anti-IgG was also performed. That allowed comparison to be made
between CNTs and NMBs labels under same conditions. The resistance measurements of
immobilized CNTs and NMBs as separate labels at the capture zone was performed. A plot of the
resistance measurements obtained against concentration of anti-IgG is shown in Figure 3.17. As
can be observed in Figure 3.17, continuous decline in the resistance within the capture zone was
observed when the zone was exposed to an increasing anti-IgG concentrations. This pattern was
observed for both CNT and NMBs labels and was attributed to the formation of interconnecting
conducting pathway due to the capture of more CNTs/CNFs. The network of NMBs formed were
more visible even at low anti-IgG concentrations compared to those formed by the CNTs.
Electrical resistance of the capture zone also reduced drastically as shown in Figure 3.17.
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Figure 3.17 Variation of the resistance of the capture zone with anti-IgG concentration for
immobilized NMBs and CNTs.

At anti-IgG concentration of 0.002 ng/ml, the resistivity obtained was the same as that of the plain
glass. Change in resistivity was first observed when a concentration of 0.004 ng/ml anti-IgG was
used for NMBs immobilization. This set a detection limit for our immunosensor. At anti-IgG
concentrations above 5 ng/ml resistivity gradually started to reach a plateau. At higher
concentrations, (> 10 ng/ml) saturation occurred. Hence, further increases in the number of
captured NMBs did not result in any significant changes in the resistivity. These measurements
formed the basis for the quantification of our immunosensor.

As shown in Figure 3.17, the change in measured resistivity was amplified when NMBs were used
as labels compared to CNTs. This makes NMBs very sensitive to detection of the slightest changes
in concentration of antigens. A detection limit of 0.01 ng/ml IgG concentration was obtained for
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the CNTs. Below this limit, all measurements were approximately equal to the that of the untreated
glass slides. Hence, NMBs have a far lower detection limit compare with that of CNTs. This
comparable low detection limit was attributed to the several millions of CNFs on a glass
microballoon. This gives NMBs better control, larger surface area and higher probability of capture
of biomolecules.

The NSB of NMBs to the capture zone was also tested to check for the possibility of false alarm.
No NMBs were observed on the capture zone in the absence of anti-IgG. The resistance
measurement of the NSB test was obtained to be 8.74 × 1010 Ω-cm which is comparable to the
9.30 × 1010 Ω-cm obtained for the glass slide. Resistance changes can therefore be attributed to
the change in concentration of anti-IgG. The successful elimination of NSB reduces the generation
of false positives and hence minimization of false alarms of the sensor.

3.8

Summary

The successful immobilization of biomolecules on NMBs fabricated in the laboratory was
demonstrated in this study. This was achieved through the use of competitive and sandwich
immunoassay protocols and the results confirmed through fluorescence studies. The fluorescence
results paved the way for studies into the potential use of NMBs as ultra-low detection labels in
RDTs. Using glass slide as a substrate and antibody conjugated NMBs as labels, various
concentrations of anti-IgG have been immobilized. The density of the immobilized NMBs network
formed varies with the concentration of anti-IgG detected. This network generates both
colorimetric and conductimetric signaling which relates to the amount of anti-IgG detected. Both
signals generated are inexpensive, simple, and dependable.
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Substituting NMBs with CNTs for the anti-IgG detection generated weaker signals. This can be
attributed to signals being generated from fewer CNTs compared to the several millions of CNFs
found on each glass microballoons. Therefore NMBs provide better ease of handling while
offering a higher sensitivity of detection compared to the CNTs.

NMBs can therefore be utilized to achieve ultra-low detection limit in RDTs. Integration of
millions of carbon nanofibers arranged on such micro-particles provided a higher probability of
detecting minute concentrations of antigen in analyte. The NMBs also offered significantly higher
level of sensitivity, as well as, simple and fast visual and/or electrical identification as labels in
RDTs. It also has an added advantaged of eliminating false-alarms while reducing the incubation
period required for detection.
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CHAPTER 4
ULTRA-LOW IMMUNOASSAY DETECTION OF MALARIA AND PREGNANCY IN
HUMANS
4.1

Introduction

Rapid immunoassay test configuration use antibodies (Ab) to react with antigens and have been
developed using a monoclonal – polyclonal (MoAb-PoAb) sandwich assay format. This format is
well suited for use in malaria and pregnancy test kits. The primary MoAb is bound to solid
substrates. Positive samples are introduced and react with immobilized MoAb. The flow rate of
the excess fluids are controlled and channeled to a non-reactive part of the substrate. Secondary
PoAb and labeling conjugate are then reacted and results obtained a few minutes thereafter [163].
This flow through mode of testing utilizes a disposable plastic cassette or strip. This type of test
requires little sample processing, is cheaper, and generates a yes/no answer without the use of an
instrument. However, they are not as sensitive as chemical chromatographic methods [164].

Sensitivity is a measure of the reproducibility of sample data from various measurements. This is
affected by both the uniformity of the test and the analyst’s technique. It is measured by conducting
several analyses of a sample or a control sample and calculating the relative standard deviation
[165]. As with all bioassays, the inherent variability between replicate measurements makes it
necessary to validate most immunoassays tests against their gold-standards. This validation
eliminates the possibility of presenting both false positive and false negative results [164]. Control
tests are incorporated to validate the accuracy of the immunoassay tests. Malaria and pregnancy
test kits integrate both the test and control runs in the same setup.
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Malaria is the most significant tropical disease known to man. It is estimated that 3.3 billion people
(living in 107 countries), almost half of the world’s population (as shown in Figure 4.1), live in
areas where malaria transmission occurs [166]. Approximately 300 to 500 million cases of clinical
malaria occur each year with about 90% of all malaria deaths occurring in sub-Saharan Africa
[166, 167]. Malaria is spreading as a result of environmental degradation, civil disturbances,
misplaced populations, increasing travel and drug resistance [168]. Children have been the most
affected due to their vulnerability to infection. One in every 5 infant deaths is attributed to malaria
[169]. The disease is preventable and curable. As such, various organizations continue to invest
resources in its management.

Figure 4.1

Global distribution of malaria endemicity [170].

Rapid and accurate malaria diagnosis is therefore essential to the management of the infection in
the affected communities [169]. The gold-standard for malaria treatment still remains the
microscopic examination of blood; thick and thin stains [171]. Research into antigen detection and
molecular detection assays are also on the rise. These methods are used as alternatives to the
traditional microscopy method. Subjective diagnosis have also been used in low resource settings
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for early treatment of malaria. However, malaria rapid diagnostic test kits (MRDTs) have a much
greater potential of reaching most affected population due to their low cost, simplicity, rapid, ultra
sensitivity and selectivity of identifying Plasmodium species.

Pregnancy on another hand is a clinical condition that involves the fertilization and development
of an embryo in a woman’s uterus [172]. On average, a pregnancy with a single embryo lasts 40
weeks from the first day of the last menstrual period. Most women are anxious to know the start
of their pregnancy, whereas it may provide a health risk for others and as such needs an early
diagnosis. Pregnancy diagnosis requires a multifaceted approach using three tools. These
approaches involve the history and physical examination, ultrasonography, and laboratory
evaluation [173]. The woman’s menstrual pattern gives healthcare providers an idea of an early
pregnancy. Physical examination are then carried out to determine enlarged uterus, breast changes,
and softening and enlargement of the cervix to confirm or dispel the pregnancy diagnosis [174].
Ultrasound-based diagnostic imaging technique is also used to confirm a normal pregnancy and
the age of a baby. It is usually done 12 weeks after the first day of the last menstrual period.

Laboratory diagnostic involves the measuring and monitoring of the quantity of human chorionic
gonadotropin (hCG). The hCG levels increases significantly after fertilization. The four assays
used for hCG determination are the radioimmunoassay, immunoaradiometric assay, enzymelinked immunosorbent assay and fluoroimmunoassay. These assays are highly specific for hCG
with antibodies directed against 2 or more isotopes on the intact hCG molecule. Blood and urine
samples are used for analyses. Urine devices are formulated to detect hyperglycosylated hCG, the
key molecule in early pregnancy [173].
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4.2

Malaria

Malaria infection is caused by the Plasmodium parasites. Plasmodium is a one-cell organism which
spread in humans through infected mosquito bites and during blood transfusion. The female
Anopheles mosquito bite is responsible for the spread. The bite is necessary to support the
nurturing of her eggs [166]. More than 100 different species of Plasmodium exist and have been
reported to produce malaria in many types of animals and birds, as well as in humans [167]. Four
of the Plasmodium species that commonly affect humans are the P. falciparium, P. vivax, P. ovale,
and P. malariae [169].

The bite of the female Anopheles mosquitoes leads to the feeding of malaria causing parasite
(called sporozoites) into the blood stream of humans. The four different species of Plasmodium
have similar life cycle with minor variation. The general life cycle is shown in Figure 4.2. The
sporozoites travel to the liver and invade the liver cells. They grow, divide, and produce tens of
thousands of a different form of sporozoites called the merozoites in each liver. Majority of the
merozoites then exit the liver cells into the bloodstream infecting the red blood cells (RBCs) in the
process. The minority of merozoites remain dormant in the liver causing relapses weeks or month
later. The merozoites multiply inside the RBCs, break open within 1 – 3 days, and infect more
RBCs. This results in several thousands of parasite-infected RBCs in the bloodstream [167].

Malaria symptoms occur a few days after an infective mosquito bite. This period, known as
incubation period, varies between 7 to 30 days. The variation of the incubation periods depends
on the type of Plasmodium parasite. P. falciparum symptoms occurs early with the less deadly P.
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malariae symptoms occurring after longer incubation periods [169]. Symptoms occur in cycles of
48 to 72 hours coinciding with the bursting of infected RBCs [167].

Figure 4.2

The life cycle of the malaria parasite [167].

The initial malaria attack lasts for 6 – 10 hours. It consists of a cold stage (sensation of cold and
shivering), a hot stage (fever, headaches, vomiting, and seizures in young children), and a sweating
stage (sweats, return to normal temperature, and tiredness) [169]. In malaria prone regions,
residents often recognize these initial signs. They begin treatment with on-the-shelf medications
without seeking diagnostic confirmation of the type of Plasmodium species.
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The type of Plasmodium species infection determines the extent of the malaria attack. Symptoms
from P. malariae are hardly observed due to the low level of parasitemia produced. P. vivax and
P. ovale infections only show symptoms between attacks. The paroxysms subside within a few
weeks even without treatment. P. vivax and P. ovale are able to infect only young RBCs. Hence
the number of parasites in the blood does not reach the same high levels as observed for the P.
falciparum infection. The body is able to develop antibodies over time subsiding the infection even
without treatment. P. falciparum infected individuals may feel miserable even between attacks and
may lead to death if treatment is delayed. The severity of this attack is due to the ability of the P.
falciparum parasites to infect RBCs in all stages of their development. Very high levels of
parasitemia are present in the blood resulting in severe symptoms only after a few days [169].

P. falciparum parasites are mainly found in tropical parts of Africa and are responsible for the
severe complications reported. Serious complications observed include cerebral malaria (abnormal
behavior, impairment of consciousness, seizures, coma, or neurologic abnormalities), severe
anemia due to hemolysis (destruction of RBCs), hemoglobinuria (hemoglobin in the urine), rupture
of the spleen, acute respiratory distress syndrome (ARDS) (an inflammatory reaction in the lungs
that inhibits oxygen exchange), abnormalities in blood coagulation, low blood pressure caused by
cardiovascular collapse, acute kidney failure, and hypoglycemia (low blood glucose) [169, 170].

4.3

Diagnosis of Malaria

Rapid and precise diagnosis of malaria is integral to the appropriate treatment of affected
individuals. This also prevents the further spread of infection in the community. In low resource
settings, clinical features of malaria are not specific and presumptive diagnosis is generally used.
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Healthcare professions use symptoms and physical findings at examination to predict the presence
of the disease. This presumptive diagnosis is not reliable. The designs of more reliable clinical
algorithms have helped to accurately diagnose malaria. The designs include microscopy,
immunology, molecular, and serology [169].

4.3.1 Microscopy
Microscopy is an established and relatively simple technique that is familiar to most laboratory
technicians. This approach remains the gold standard for laboratory confirmation of malaria
because of its sensitivity, specificity, and ability to quantify the parasitemia level [175-177].
However, it is labor intensive and time consuming [178]. The limitation of this method arises when
mixed infections are present at low parasitemia levels. Highly trained personnel are also required
in the use of the microscopes as well as in sample preparation. There are two main types of sample
preparation for the microscopy test: thin and thick films malaria smear methods. Sensitivity and
selectivity are adequately accommodated using the thick and thin films malaria smears,
respectively.

In thick film smear, the RBCs are approximately 6 – 20 layers thick resulting in a larger volume
of blood being used and ability to detect very low parasitemia. As few as 5 parasites/µl of blood
can be determined [179]. Thick film is used to determine the presence of parasites. In examining
the thick blood films, the RBCs are lysed (destroyed) making it difficult to differentiate between
the various Plasmodium species. In thin films, the RBCs are fixed so the morphology of the
parasitized cells is easily seen. Species identification is clearly made based on the size and shape
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of the various stages of growth of the parasites. The presence of stippling (bright red dots) and
fimbriation (ragged ends) are also clearly seen [180].

4.3.2 Molecular
The use of molecular methods has been reported to yield higher sensitivity, detect mixed
infections, and to accurately identify Plasmodium species [177, 178, 181]. However, all the
methods that rely on this method are relatively expensive and require a specialized laboratory
setup. The results are also not available quickly enough to be of value in establishing the diagnosis
of a malaria infection. Therefore, molecular tests are used as complementary tools for the diagnosis
of malaria in some reference laboratories to accurately diagnosis low parasitemia infected patients
[177]. While this methodology is unlikely to be useful at the peripheral level of healthcare, it may
have a place as a research tool to monitor malaria control programs.

The molecular diagnostic tests include polymerase chain reaction (PCR), loop-mediated
isothermal amplification (LAMP), mass spectrometry (MS), and flow cytometric (FCM) assay
techniques. PCR-based techniques are used extensively to confirm malaria infection, follow-up
therapeutic response, and identify drug resistance [182]. High cost has limited its use in lowresource settings. The LAMP method is relatively easier, sensitive, quick, and cheaper than PCR.
However, its reagents require cold storage, and further trails are needed to validate its feasibility
and clinical utility [183]. MS has been reported to be rapid, high throughput, and can be automated
[184]. FCM has the advantage of diagnosing clinically unsuspected malaria. The disadvantages of
the MS and FCM techniques are their costly diagnostic equipment, labor intensive, and the need
for trained technicians [184]
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4.3.3 Serology
The diagnosis of malaria using the serological methods is mostly based on the detection of
antibodies against the macrogametocytes and microgametocytes malaria parasites. The main use
of this method is for retrospective studies, particularly for epidemiological purposes and for tracing
asymptomatic

infections

in

blood

donors.

The

various

serological

tests

include

immunofluorescence antibody test (IFA), enzyme-linked immunosorbent assay (ELISA),
radioimmunoassays, latex agglutination, indirect haemagglutination, and solid-phase dipstick and
membrane dot-blot.

The IFA test is the main method for routine serology testing. It is relatively easy to setup and
highly sensitive and specific [185]. This serological method is not widely used for malaria
diagnosis because it is time consuming and cannot be automated limiting the number of sera that
can be studied daily. IFA requires the use of a fluorescence microscope and trained technicians.
Readings obtained from testing are subjective based on the level of training of the technician.
Finally, the method is highly labor-intensive limiting its application to specialized centers [184].

4.3.4 Antigen Detection
Malaria antigen detection tests assist in the diagnosis of infection by providing evidence of the
presence of malaria parasites in human blood. They are commercially available and allow the rapid
diagnosis by individuals who are not otherwise skilled in traditional laboratory techniques.
Antigen-based malaria rapid diagnostic tests (MRDTs) are also cost effective, accurate and find
widespread use in low resource settings where traditional equipment are not available [184].
Currently, over 100 commercially available MRDTS have been approved by the World Health
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Organization [186]. These MRDTs are based on a lateral flow ‘immunochromatographic’
(dipstick), cassette, or card formats [169]. Although MRDTs are supposed to be rapid, it takes at
least 15 minutes for results to be displayed. BinaxNow has been reported as the fastest MRDT on
the market with an incubation period of 15 minutes [187, 188].

MRDTs are all based on the same principle: capturing of P. falciparum on a first band, all other
Plasmodium species on a second band, and a control on a third band of a nitrocellulose strip. A
lyzing agent is used for rapturing the RBCs. This makes available all merozoites available for
conjugation with immobilized antibodies.

MRDT performance for diagnosis has been reported to be excellent in several publications [182,
184, 186, 189-193]. However, several issues remain to be addressed. These include improving
their accuracy; lowering their cost; improving their detection time and ensuring their adequate
performance under adverse field conditions. The MRDTs may also not able to detect some
infections with lower numbers of malaria parasites circulating in the patient’s bloodstream.
MRDTs are also not able to differentiate between P. vivax, P. malariae and P. ovale. The use of
dyes as labels have also been reported to negatively impact on MRDTs [194]. These dyes readily
or continually undergoes chemical, physical, or biological breakdown and may not be available
for the reaction when needed. Researches into the use of other diagnostic methods are ongoing to
aid in the best management of the disease.
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4.4

Pregnancy

Pregnancy is a clinical condition that occurs between the conception and birth of a baby. Human
chorionic gonadotropin (hCG) is a critical hormone whose presence in humans can be used as a
marker for various aspects of human health. It is used as a biomarker for pregnancy detection,
gestational trophoblastic disease (GTD), germ cell tumors and some non-trophoblastic
gynecological cancers and common epithelial tumors [195-197]. Detection and quantification of
this hormone are essential during pregnancy as it gives valuable information concerning the
progress of a pregnancy.

hCG is a 37 kDa glycoprotein hormone composed of two dissimilar subunits joined non-covalently
[198]. These subunits are termed alpha and beta. Common hCG-related molecules in serum
samples include the regular hCG, hyperglycosylated hCG, nickel hCG, hCG missing the betasubunit C-terminal extension, free alpha-subunit, free beta-subunit (hCGβ), free beta-subunit
missing the C-terminal extension, hyperglycosylated free beta-subunit (hCGβcf) and nickel free
beta-subunit [196]. The same molecules and the beta-core fragment are present in urine samples.

During the early stage of conception, hCG hormone has the crucial role of maintaining the essential
steroid production ensuring that the pregnancy progresses unabated. An increase in the
concentration of hCG and its subunits becomes pronounced when the fertilized egg attaches to the
wall of the uterus. This occurrence takes a minimum of six days after fertilization [199]. These
initial concentrations are difficult to detect. However, the amount of this hormone doubles every
two or three days increasing the probability of its detection with increasing length of the pregnancy.
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Hence, most commercially available RDTs are able to correctly detect its presence only after high
concentrations of the hormone are produced.

4.5

Diagnosis of Pregnancy

hCG is found in both serum and urine of all humans with only a slight concentrations difference
observed with age and sex. The upper reference limit in serum for men has been reported as 2.1
pmol/l and in non-pregnant women as 8.6 pmol/l [200]. The upper limit of hCG in the urine of
men below 50 years is 2.9 pmol/l and 8.4 pmol/l for those older than 50 years. The corresponding
values for non-pregnant women are 8.8 and 11.5 pmol/l, respectively.

The increase in hCG and its subunits is nearly exponential during the first 5 weeks after ovulation
[201]. hCGβcf can be detected in serum during pregnancy in quantities corresponding to 0.03% of
the hCG content. The concentration in urine is about 4000 times more than found in serum [202].
hCGβcf is the major form of hCG immunoreactivity in pregnancy urine except during the first
month of pregnancy, when hCG predominates [203]. The concentrations of hCG immunoreactivity
in paired serum and urine samples are similar and correlate strongly [204]. Total hCG
immunoreactivity is higher in urine and apparently attributable to hCGβcf [200].

Specific measurement of hCG and its directives in serum became possible with the development
of ultrasensitive immunometric assays that were based on monoclonal antibodies [205]. RDTs are
also designed to detect hCG in urine.
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4.6

Experimental Procedures

4.6.1 Reagents and Materials
As-grown and functionalized NMBs were used for the study. Plasmodium falciparum histidine
rich protein-2 (PfHRP-2) antigen, Plasmodium vivax merozoites surface protein-1 (PvMSP-1)
antigen, mouse monoclonal to PvMSP1 antibody (Ms-MAbv), rabbit polyclonal to PvMSP1
antibody (Rb-PAbv), mouse monoclonal to PfHRP-2 antibody (Ms-MAbf), and rabbit polyclonal
to PfHRP-2 antibody (Rb-PAbf) were obtained from MyBioSource Inc., USA. hCG, mouse
monoclonal to hCG (Ms-hCG), and rabbit polyclonal to hCG (Rb-hCG) were also purchased from
Abcam, USA. All biological samples were obtained in a PBS solution, pH 7.4, and containing
0.1% of sodium azide.

4.6.2 NMB-Plasmodium Species Conjugation
CNFs have very high chemical affinity for biospecies [206]. A two-step reaction approach
described in Section 3.6.3 was used in preparing the NMBs for covalent conjugation with RbPAbf, Rb-PAbv, and Rb-hCG. This reaction forms an ester intermediate on the NMBs that aids
the amidation reaction. The amidation reaction involves the reaction of the intermediate with the
primary amine group on the surfaces of Rb-PAbf. Same procedure was followed for the covalent
conjugation of NMBs with Rb-PAbv, and Rb-hCG. Very strong amide bonds were formed in each
of the processes [127]. PEG was then applied forming a polyethylene oxide coating on NMBs.
This coating prevents NSB of unwanted proteins to the NMBs.
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4.6.3 Preparation of Glass Substrate
Single and double capture zones marked on several slides were used for the study. Slides were
thoroughly cleaned, modified, and activated with amino functional groups as described previously.
All capture zones were treated to prevent NSB with unwanted proteins. Details of immobilization
Ms-MAbf, Ms-MAbv, and Ms-hCG on glass slides to capture PfHRP-2, PvMSP-1, and hCG
respectively based on sandwich immunoassay protocol is described in Section 3.6.4.

First, Ms-MAbf was immobilized on glass slides with single capture zone marks. The capture zone
was used for sandwich immunoassay investigation of PfHRP-2 with concentrations in the linear
range of 0.01 ng/ml and 10 ng/ml. Similarly, Ms-hCG immobilized on other single marked capture
zone slides was used to investigate the capture of hCG in the linear range of 0.025 ng/ml and 10
ng/ml. The visual and electrical detection limits of the PfHRP-2 and hCG were determined within
their specific ranges.

Second, for the glass slides with double capture zones, Ms-MAbf were immobilized on the first
capture zone and Ms-MAbv on the second capture zone. Same immunoassay procedure was then
executed. For performance evaluation, PfHRP-2 was caught at the first capture zone. Experiment
was repeated using PvMSP-1 sample in PBS with concentrations ranging from 0.01 ng/ml to 10
ng/ml. PvMSP-1 was caught at the second capture zone and the detection limits of PvMSP-1 in
PBS solution was obtained.

Third, solutions made up of equal amounts of PfHRP-2 and PvMSP-1 samples were also prepared.
Concentrations in the range of 0.01 ng/ml and 10 ng/ml for both antigens were used for the study.
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Similarly, it was observed that PfHRP-2 was caught at the first capture zone and PvMSP-1 at the
second capture zone. This allows the identification of both antigens from the same mixed sample.
Scanning electron microscopy (SEM), optical microscopy, and electrical resistivity
characterization were performed. The procedure and equipment for the characterization was
reported in the previous chapter.

4.6.4 Characterization
The morphology of the Plasmodium species was studied using an Olympus CH Binocular
microscope fitted with a 100× objective with a 1.25 N.A.

4.7

Results and Discussion

4.7.1 Principle of Disease Detection
Most MRDTs currently employ the immunochromatographic strip assay technique. This technique
allows for separation and identification of soluble antigens in solution using complementary
antibodies. The technique allows for mass production of kits, which in turn allows lower
manufacturing and distribution cost, and a simplified supply chain. The strip assay technique also
allows for easy training of users, standardization of result interpretation, and ease of use in
countries or regions where multiple languages are spoken [207].

Similarly, the NMBs detection technique is based on the immunochromatography sandwich
approach. As a result of specific binding between the capture antibody and antigen, visible signal
is generated from the NMBs conjugated with secondary antibody. The optical signal is assessed
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using the naked eye and quantified using a reading device. Immobilized NMBs on the capture zone
can also be quantified using the change in electrical resistivity of that capture zone.

The success of the sandwich immunoassay test requires the use of an antigen large enough to
contain at least two epitopes [165]. PfHRP-2, which satisfies this requirement, has two epitopes
specific to Ms-MAbf and Rb-PAbf. The primary monoclonal antibody, Ms-MAbf, was
immobilized on the capture zone of the glass slide as shown in Figure 4.3 (a). PfHRP-2 in PBS
was applied to the sample pad of the strip. Extra PBS was introduced and acts as a lysing agent to
improve the sample flow to the absorption pad. The sample mixture migrated across the membrane
to the capture zone, where Ms-MAbf immobilized on the strip surface captured most of the PfHRP2 present in the mixture. The absorption pad regulated the flow and collected all excess fluid. A
second liquid specimen of the secondary polyclonal antibodies, Rb-PAbf, coupled to NMBs in
PBS was applied to the sample pad. The Rb-PAbf and NMBs conjugate bind to different epitopes
on the captured PfHRP-2 antigens. As a result, the Rb-PAbf and NMBs conjugate captured by the
PfHRP-2 generated a dark line at the capture zone, giving a positive test result shown in Figure
4.3 (b). Electrical resistivity of the capture zone can also be obtained {Figure 4.3(b)}.

4.7.2 Detection Limit of PfHRP-2 Assay
Successful immobilization of NMBs on the capture zone of the glass slide was achieved within
one minute. NMBs were observed to form an interconnecting network at the capture zone as shown
in Figure 4.4. This network confirmed the detection of PfHRP-2 by the sandwich
immunochromatography method. Increasing PfHRP-2 concentration increased the density of the
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immobilized NMB network at the capture zone. This is depicted in Figure 4.4 for four different
concentrations of PfHRP-2 studied.
(a)
Sample pad

Capture
zone

Absorption pad

Glass slide
Apply
PfHRP-2/PBS
Rb-PAbf conjugated to NMB

Rb-PAbf
PfHRP-2
Apply
NMB/Rb-PAbf/PBS

Ms-MAbf

(b)

Figure 4.3
(a) Schematic illustration of the sandwich immunochromatographic set-up used to
detect PfHRP-2 and (b) Illustration of the two different types of signal generation from the
immunosensor. The yellow cable is used for electrical measurements.

The network of immobilized NMBs at the capture zone for the various PfHRP-2 concentrations
were characterized. A linear relationship between the percentage area covered by the NMBs (Apct)
at the capture zone and the concentration of PfHRP-2 in the range of 0.01 ng/ml to 10 ng/ml was
attained {shown in Table 4.1 and Figure 4.5 (a)}. The correlation equation, 𝐴𝑝𝑐𝑡 = 0.7212 +
1.286𝑥 (𝑅 2 = 0.9968) was used, where x is the concentration of PfHRP-2. With high coefficient
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of determination, this equation can be used to estimate the concentration of Plasmodium
falciparum in any sample tested. The visual detection limit of the assay was obtained to be 0.025
ng/ml. This is the lowest concentration at which the NMB network was observed with the unaided
human eye.

(a)

(b)

(c)

(d)

Figure 4.4
Optical micrographs showing NMBs captured on glass slides in a sandwich assay
format with (a) 0.025, (b) 0.1, (c) 1, and (d) 10 ng/ml concentrations of PfHRP-2.

Table 4.1
Summary of the percent area of the capture zone covered with NMBs for varying
PfHRP-2 concentrations.
Concentration
(ng/ml)
0.025
0.05
0.1
1.0
10.0

Percent Area Covered
by NMBs
0.52
0.62
0.75
2.56
13.53
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Standard
Deviation
0.13
0.33
0.43
0.37
0.84

16
14

Percent Area Covered by NMBs

(a)

y = 1.286x + 0.7212
R² = 0.9968
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Figure 4.5
(a) Variation of percent area of the capture zone covered with NMBs against
PfHRP-2 concentrations and (b) Variation of the resistivity of the capture zone with immobilized
PfHRP-2 concentration. The error bars in both graphs each shows the variation of five
concentration points.
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The lowest detection limit of PfHRP-2 reported in the literature to date using immunoassay
technique has been 0.36 ng/ml [208]. The ultra-low visual detection limit of 0.025 ng/ml obtained
from this study is attributed to the following. First, the high aspect ratio of CNFs makes available
several binding sites for covalent bonding with Rb-MAbf. The high aspect ratio arises from the
construction of the CNFs giving them length-to-diameter ratio of up to 132,000,000:1. This high
ratio gives CNFs extensive area on their length for several of the nanosized antigens to be
immobilized. Second, the exploitation of the high chemical reactivity of CNFs with antibodies of
PfHRP-2 and organic surfactants make it possible for CNFs to be highly selective and specific in
aqueous environment. Third, large effective surface area remains available on each
microstructured NMB allowing it to be treated with several millions of PfHRP-2 antibodies.
Finally, the microstructure of the NMBs allows visual signal amplification and hence easier
quantification.

Signal detection and quantification of this immunosensor can also be achieved using electrical
measurement. The high conducting nature of CNFs [59] provides the flexibility to perform
resistivity changes on the capture zone of the immunosensor in addition to the visual
characterization. The interconnected pathway formed by the immobilized NMBs at the capture
zone allowed for an effective electron transfer to be established with the electrode. The resistivity
of the capture zone was measured at different PfHRP-2 concentrations as shown in Figure 4.5(b)
and Table 4.2. The higher the concentration of PfHRP-2, the higher was the density of the
immobilized NMBs and hence the more the CNFs available for conduction. Resistivity of the plain
glass slide used for the study was obtained as 9.30 × 1010 Ω-cm. Resistivity measurement was also
conducted in NSB case and it was measured as 8.99 × 1010 Ω-cm. Appreciable change/reduction
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in resistivity was only observed for concentrations of PfHRP-2 0.01 ng/ml and greater. This set a
limit of detection for PfHRP-2 as 0.01 ng/ml, which is considered very low.

Table 4.2
Summary of the measured resistance values of the capture zone for varying PfHRP2 concentrations.
Concentration
(ng/ml)
0.025
0.05
0.1
1.0
10.0

Resistivity
(Ωcm)
4.39E+10
3.57E+10
1.13E+10
4.02E+08
2.46E+06

Standard
Deviation
7.50E+09
1.78E+10
2.89E+09
4.31E+08
3.63E+06

4.7.3 Selectivity of the PfHRP-2 Detection Assay
The selectivity performance of the proposed method was also established. In order to determine
this capability, two capture zones were identified on the immunosensor. On the first capture zone,
primary antibodies specific to PfHRP-2 were immobilized. Antibodies specific to PvMSP-1 were
immobilized on the second capture zone. Using the same method as described earlier, the technique
was able to capture different densities of NMB networks on the first zone when varying
concentrations of PfHRP-2 in PBS solution was applied on the sample pad. Figure 4.6 (a) shows
the immunosensor for the detection of 10 ng/ml of PfHRP-2 in PBS solution. Quantification of the
percent area covered by captured NMBs showed similar pattern to the graph displayed in Figure
4.5 (a). During the tests with various concentrations of PfHRP-2, no NMBs were observed at the
second capture zone.
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(a)

(b)

(c)

Figure 4.6
Glass slides showing (a) visual signal obtained at the first capture zone from the
detection of PfHRP-2 in PBS solution, (b) signal observed at the second capture zone from the
detection of PvMSP-1 in solution, and (c) signals obtained at the PfHRP-2 and PvMSP-1 capture
zones from a mixed PfHRP-2 and PvMSP-1 solution.

The assays with varying concentration of PvMSP-1 in PBS showed a colored signal only at the
second capture zone. Figure 4.6 (b) shows the immunosensor for the detection of 10 ng/ml of
PvMSP-1 in PBS solution. Both optical and electrical characterizations were performed on the
captured NMB network at the second capture zone. Similar to the microscopic characterization of
PfHRP-2, a linear relationship between Apct at the capture zone and concentrations of PvMSP-1
was obtained {shown in Figure 4.7 (a) and Table 4.3}. The correlation equation was 𝐴𝑝𝑐𝑡 =
0.6133 + 2.1059𝑥 (𝑅 2 = 0.9902). Likewise, R2 has a good correlation and can be used to
estimate the concentration of Plasmodium vivax in any sample tested. The visual detection limit
of the assay was obtained to be 0.025 ng/ml. The lowest detection limit of PvMSP-1 reported in
the literature using immunoassay technique is 6.3 ng/ml [209]. The limit of detection using
electrical measurements for the detection of PvMSP-1 was obtained at 0.02 ng/ml {Figure 4.7 (b)
and Table 4.4}.

In another set of tests, a solution containing equal concentrations of PfHRP-2 and PvMSP-1 in
PBS was prepared. The concentration of both antigens used for the study ranged from 0.025 ng/ml
to 10 ng/ml. In all the tests performed, NMBs were observed to be captured selectively on both
capture zones. Figure 4.6(c) shows the immunosensor with specific NMBs at both capture zones.
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Figure 4.7
(a) Variation of percent area of the capture zone covered with NMBs against
PvMSP-1 concentrations and (b) Variation of the resistivity of the capture zone with immobilized
PvMSP-1 concentration.
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Table 4.3
Summary of the percent area of the capture zone covered with NMBs for varying
PvMSP-1 concentrations.
Concentration
(ng/ml)
0.025
0.05
0.1
1.0
10.0

Percent Area Covered
by NMBs
0.53
0.75
0.93
2.70
21.67

Standard
Deviation
0.11
0.11
0.13
0.19
1.09

Table 4.4
Summary of the measured resistivity values of the capture zone for varying
PvMSP-1 concentrations.
Concentration
(ng/ml)
0.02
0.025
0.05
0.1
0.5
1.0

Resistivity
(Ωcm)
6.30E+10
4.32E+10
1.41E+10
9.91E+09
2.20E+09
3.95E+08

Standard
Deviation
1.82E+10
3.22E+09
4.28E+09
1.80E+09
8.29E+08
3.40E+07

4.7.4 Selectivity of the hCG Detection Assay
hCG, the clinical condition responsible for the diagnosis of pregnancy, was also tested using the
immunochromatographic approach as described previously. Ms-hCG was initially immobilized on
the glass substrates with Rb-hCG conjugated to the NMBs. Varying the concentration of hCG in
PBS, different densities of NMB networks were immobilized on the capture zone. The correlation
equation of Apct = 0.4596 + 1.6452x (R2 = 0.9838) was obtained after optical characterization of
the NMB networks. This linear relationship is shown in Table 4.5 and Figure 4.8 (a). The visual
detection limit of the assay was obtained as 0.05 ng/ml. The lowest detection limit of hCG reported
in the literature using immunoassay technique is 0.5 ng/ml [210]. The limit of detection using
electrical measurements for hCG capture was also obtained as 0.025 ng/ml {Figure 4.8 (b) and
Table 4.6}.
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Table 4.5
Summary of the percent area of the capture zone covered with NMBs for varying
hCG concentrations.
Concentration
(ng/ml)
0.05
0.10
0.50
1.00

Percent Area Covered
by NMBs
0.43
0.72
1.33
2.08

Standard
Deviation
0.15
0.14
0.18
0.18

2.5

Percent Area Covered by NMBs

y = 1.6452x + 0.4596
R² = 0.9838
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Figure 4.8
(a) Variation of percent area of the capture zone covered with NMBs against hCG
concentrations and (b) Variation of the resistivity of the capture zone with immobilized hCG
concentration.
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Table 4.6
Summary of the measured resistance values of the capture zone for varying hCG
concentrations.
Concentration
(ng/ml)
0.025
0.05
0.1
0.5
1.0

4.8

Resistivity
(Ωcm)
6.17E+10
6.50E+10
3.55E+10
5.90E+09
1.67E+09

Standard
Deviation
2.29E+10
1.26E+10
8.77E+09
1.11E+09
6.75E+08

Summary

The higher probability of capture available to biological species on the novel NMB particles made
it possible for the immunochromatographic sandwich approach to be used in diagnosing various
clinical conditions. hCG, the hormone used in the detection of pregnancy was tested. P.
falciparium and P. vivax, the two most deadly parasites responsible for the majority of severe
malaria cases were also detected in this study. Ultra-low visual detection limits were obtained for
all three clinical conditions studied. The method was rapid with detection being achieved within
one minute of testing. The approach was also able to selectively capture the required antigen at
different capture zones within the immunosensor.

This unbeatable simplicity, speed of the technique, specific, and ultrasensitive approach makes the
process very selective with a potential for establishing a visual quantitative relationship for varying
antigens concentration. Further validation and quantification of results were achieved by
measuring the change in resistivity within the capture zone. Compared with RDTs which required
the

addition

of

dyes

and

enzymatic

substrates

to

the

detection

solution,

the

immunochromatographic sensor proposed in this work avoided the limitations resulting from the
requirement of these substrates. The immunosensor exhibited a reliable accuracy and proved to be
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practical and convenient. This method highlights the potential strategy that can be substituted in
RDTs in general. This will usher in, a highly effective RDTs to improve the overall global
healthcare system.
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CHAPTER 5
CONCLUSIONS AND FUTURE WORK
5.1

Conclusions

5.1.1 Surface Functionalization of NMBs
Carbon nanofibers (CNFs) were grown on nickel coated glass microballoons (NMBs) using the
dual zone chemical vapor deposition (CVD) technique. The growth process deposited residual
amorphous carbonaceous fragments on the NMBs. The amorphous carbon was removed through
surface functionalization. The surface functionalization resulted in the production of cleaner
NMBs and also the formation of carboxyl and hydroxyl functional groups on the surface of the
NMBS. Functionalization was carried out in nitric acid, nitric/sulfuric acid, and air oxidized
environments. The acidic modified NMBs led to substantial loss of CNF structure while the air
oxidized process maintained the CNF structure. Acidic treated NMBs were also found to
negatively impact on biological species and hence not suitable for use in biosensors. Air oxidized
NMBs therefore stands out as the ideal surface treatment approach.

The air oxidized NMBs preserved their structure and were able to maintain good dispersion in
water for two minutes. Suspension stability was observed to reduce drastically with nitric acid
having the weakest stability and air oxidized the best among the nitric, nitric/sulfuric acid and air
oxidized methods. Reduction in suspension stability occurs by dispersed NMBs coalescing at the
bottom of the containers while the remaining NMBs float on the water surface. The floating NMBs
were due to the hollow nature of the microballoons. Air oxidation also introduces carboxyl and
hydroxyl functional groups to the surface of the NMBs. FTIR studies confirmed the presence of
the carboxyl and hydroxyl groups. These functional groups are needed for conjugation with
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biological species in biosensors. Hence, NMBs with the potential of improving the performance
of rapid diagnostics test kits (RDTs) was successfully fabricated and functionalized.

5.1.2 Conjugation of Biological Species to NMBs
The integration of millions of CNFs arranged on such micro-particle provided a higher probability
of attaching several millions of biological species to the NMBs. The ability of CNFs to form
countless combination and derivatives was exploited to develop next generation sensors.
Biological species were covalently bonded to the CNFs through an amidation process by taking
advantage of the EDC/Sulfo-NHS activation method. Non-covalent bonding of PEG to the NMBs
was also accomplished. The PEG organic molecules covered the sidewalls of the CNFs providing
a nano-scale coating that led to the prevention of non-specific binding during the sensing
application.

Competitive and sandwich immunoassay formats were demonstrated using IgG and anti-IgG and
the results confirmed through fluorescence studies. The fluorescence results paved the way for
studies into the potential use of NMBs as ultra-low detection labels in RDTs. Using glass slide as
a substrate and antibody conjugated NMBs as labels, various concentrations of anti-IgG were
immobilized. The density of the immobilized NMBs network formed varies with the concentration
of anti-IgG detected. Electrical resistivity measurements of the test zone showed the potential for
establishing a quantitative relationship for the antigen concentration. Ultra-low detection limit of
4 pg/ml was obtained from electrical signaling. Visual detection was also achieved due to the dark
nature of the NMBs at the capture zone. As low as 0.1 ng/ml of anti-IgG were observed with the
unaided eye at the test zone. The NMBs offered significantly higher level of sensitivity, as well as,
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simple and fast visual and/or electrical identification of IgG/anti-IgG on the test glass slides. This
novel approach holds the promise for early detection of various diseases, as well as providing
healthcare professionals with information regarding the stage of infection. Utilizing this type of
label could also lead to the elimination of false-alarms while reducing the incubation period
required for detection in currently used RDTs.

5.1.3 Pathogen Detection on Immunochromatographic Device
The methodology developed for fabricating, functionalizing and conjugating of NMBs with
biological species was applied in detecting two major clinical conditions. P. falciparium and P.
vivax, the two most deadly parasites responsible for the majority of severe malaria cases, were
detected in this study using the immunochromatographic sandwich approach. P. falciparum
histidine rich protein-2 (PfHRP-2) and P. vivax merozoites surface protein-1 (PvMSP-1) antigens
were tested over their linear range of 0.01 – 10 ng/ml. The approach was ultrasensitive and highly
selective with visual detection limit of 0.025 ng/ml obtained for both PfHRP-2 and PvMSP-1 in
PBS at two different test zones on the same glass slide achieving multiple disease detection.
Electrical detection limits were measured as 0.01 ng/ml for PfHRP-2 and 0.02 ng/ml for PvMSP1. hCG, the clinical condition responsible for the diagnosis of pregnancy, was also tested at a linear
range of 0.025 – 10 ng/ml. Visual detection limit of 0.05 ng/ml and an electrical detection limit of
0.025 ng/ml were obtained. The ultra-low limits obtained for both visual and electrical detection
for the two clinical conditions have never been achieved using RDTs in the field nor in the lab as
provided in the literature.
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The use of WAG RDTs avoided the limitations commonly encountered from the use of dyes and
enzymatic substrates in RDTs. This detection process is reliably accurate, practical and convenient.
Thus, the highly reactive, rapid, selective and signal amplification capabilities of NMBs is a
promising tool for use in MRDTs and pregnancy test kits for the early diagnosis of these clinical
conditions.

5.2

Future Work

5.2.1 Pathogen Detection in Microfluidic Device
The developed immunochromatographic device (WAG RDT) in this study was able to effectively
detect ultra-low concentrations of antigen within a minute of analysis. However, all the reagents
integral to the process are expensive and therefore miniaturization will reduce the cost and
efficiency drastically. Miniaturization can be achieved by using a microfluidic immunosensing
device. Microfluidic devices consist of microchannels for transporting fluids, with part or all of
the necessary components of the immunoassay procedure integrated in the device [211]. A
microfluidic device reduce diffusional distances limiting analysis time and enabling more rapid,
POC diagnostics that significantly enhances the speed of the process. Microfluidic devices are
passive requiring no external power input, but instead relying on diffusion and/or capillary action
to control the assay [212, 213]. Precision is drastically improved in microfluidic devices by using
software linked to pumps, valves, mixers, etc., to control the movement of fluids.
Successful immobilization of antibodies on interdigitated array (IDA) microelectrodes fabricated
on a glass substrate and incorporated within microfluidic immunosensing device has been achieved
[140]. Similarly, a microfluidic device suitable for the conjugate used in this study need to be
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designed. Studies on optimizing the detection process in the microfluidic device must be carried
out.

5.2.2 Design and Optimization of Microfluidic Device
Microfluidic immunosensing has been demonstrated using CNT matrix [140]. Human serum
albumin (HSA) protein in a sandwich assay format and polydimethylsiloxane (PDMS)
microfluidic system were used. The microfluidic system allowed passive sample transport to the
test zone by capillary action. The test zone had an IDA microelectrode on which primary anti-HSA
was immobilized. Secondary anti-HSA conjugated with CNTs formed a conducting matrix across
the IDA which generated electrical signal equivalent to the amount of captured HSA.

The CNT microfluidic immunosensor can be redesigned to use microsized particles of the NMBs
in place of the nanosized CNTs. The flow system within the microfluidic system will be optimized
by using a combination of a capillary pump and an absorbent pad. An optimum condition within
the system can be obtained by manipulating the dimensions of the pump, channel, test zone, and
IDA. Incorporating the conjugate solution within the system can also eliminate the application of
multiple reagents which can lead to the overall improvement in the sensitivity of the device.
Therefore further studies need to be performed in designing and optimizing the detection process
in a microfluidic device. Simulating the process will also lead to a better understanding of the
influence of the different parameters involved in the microfluidic system.
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5.2.3 Clinical Trials using Microfluidic Device
The successful diagnostic of malaria and pregnancy clinical conditions using the
immunochromatographic assay format has been demonstrated. The purified protein derivative of
the antigens of the clinical conditions were used. In RDTs, in vivo tests of antigens are rather
conducted. Hence, for completely successful use of WAG RDTs, tests on the whole genome
antigens have to be conducted. The whole genome antigen has many other components which do
interfere with in vivo immunoassay tests. Such components include polysaccharides, lipids, and
other proteins.

Detection of whole genome antigens in the microfluidic system also need to be carried out. The
statistical prediction of the confidence interval of the device from a clinical study will be performed
to determine the sensitivity and specificity of the microfluidic device. The sensitivity gives an
indication of how the device correctly identifies tested patients with the disease while the
specificity of the device provides the ability to accurately identify tested patients without the
disease [214]. Results obtained from testing a sample on the device and testing same sample using
the ‘gold standard test’ are used as basis. True positive and true negative results obtained are used
for the sensitivity and specificity calculations.
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